# num of genes	num of total genes	Log of odds ratio	P-value	Adjusted p-value	GO term ID	GO term name	GO type
2	2	6.64061170756	-	9.97e-05	GO:1901558	response to metformin	BP
2	2	6.64061170756	-	9.97e-05	GO:1904017	cellular response to Thyroglobulin triiodothyronine	BP
1	1	6.64061170756	-	1.00e-02	GO:1902253	regulation of intrinsic apoptotic signaling pathway by p53 class mediator	BP
1	1	6.64061170756	-	1.00e-02	GO:0046824	positive regulation of nucleocytoplasmic transport	BP
1	1	6.64061170756	-	1.00e-02	GO:0061326	renal tubule development	BP
1	1	6.64061170756	-	1.00e-02	GO:0051729	germline cell cycle switching, mitotic to meiotic cell cycle	BP
1	1	6.64061170756	-	1.00e-02	GO:0010522	regulation of calcium ion transport into cytosol	BP
1	1	6.64061170756	-	1.00e-02	GO:1901994	negative regulation of meiotic cell cycle phase transition	BP
1	1	6.64061170756	-	1.00e-02	GO:0043618	regulation of transcription from RNA polymerase II promoter in response to stress	BP
1	1	6.64061170756	-	1.00e-02	GO:1904998	negative regulation of leukocyte adhesion to arterial endothelial cell	BP
1	1	6.64061170756	-	1.00e-02	GO:1902396	protein localization to bicellular tight junction	BP
1	1	6.64061170756	-	1.00e-02	GO:0000117	regulation of transcription involved in G2/M transition of mitotic cell cycle	BP
1	1	6.64061170756	-	1.00e-02	GO:0010768	negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage	BP
1	1	6.64061170756	-	1.00e-02	GO:0051866	general adaptation syndrome	BP
1	1	6.64061170756	-	1.00e-02	GO:0021572	rhombomere 6 development	BP
1	1	6.64061170756	-	1.00e-02	GO:0048561	establishment of animal organ orientation	BP
1	1	6.64061170756	-	1.00e-02	GO:0006117	acetaldehyde metabolic process	BP
1	1	6.64061170756	-	1.00e-02	GO:0035624	receptor transactivation	BP
1	1	6.64061170756	-	1.00e-02	GO:0019089	transmission of virus	BP
1	1	6.64061170756	-	1.00e-02	GO:0000435	positive regulation of transcription from RNA polymerase II promoter by galactose	BP
1	1	6.64061170756	-	1.00e-02	GO:0072308	negative regulation of metanephric nephron tubule epithelial cell differentiation	BP
1	1	6.64061170756	-	1.00e-02	GO:1903755	positive regulation of SUMO transferase activity	BP
1	1	6.64061170756	-	1.00e-02	GO:0046725	negative regulation by virus of viral protein levels in host cell	BP
1	1	6.64061170756	-	1.00e-02	GO:0035042	fertilization, exchange of chromosomal proteins	BP
1	1	6.64061170756	-	1.00e-02	GO:1904353	regulation of telomere capping	BP
1	1	6.64061170756	-	1.00e-02	GO:0001543	ovarian follicle rupture	BP
1	1	6.64061170756	-	1.00e-02	GO:0098746	fast, calcium ion-dependent exocytosis of neurotransmitter	BP
1	1	6.64061170756	-	1.00e-02	GO:1903305	regulation of regulated secretory pathway	BP
1	1	6.64061170756	-	1.00e-02	GO:0090425	acinar cell differentiation	BP
1	1	6.64061170756	-	1.00e-02	GO:0043969	histone H2B acetylation	BP
1	1	6.64061170756	-	1.00e-02	GO:1900085	negative regulation of peptidyl-tyrosine autophosphorylation	BP
1	1	6.64061170756	-	1.00e-02	GO:0042659	regulation of cell fate specification	BP
1	1	6.64061170756	-	1.00e-02	GO:0061114	branching involved in pancreas morphogenesis	BP
1	1	6.64061170756	-	1.00e-02	GO:2000979	positive regulation of forebrain neuron differentiation	BP
1	1	6.64061170756	-	1.00e-02	GO:1905337	positive regulation of aggrephagy	BP
1	1	6.64061170756	-	1.00e-02	GO:1901978	positive regulation of cell cycle checkpoint	BP
1	1	6.64061170756	-	1.00e-02	GO:0002194	hepatocyte cell migration	BP
1	1	6.64061170756	-	1.00e-02	GO:1904639	cellular response to resveratrol	BP
1	1	6.64061170756	-	1.00e-02	GO:1904635	positive regulation of glomerular visceral epithelial cell apoptotic process	BP
1	1	6.64061170756	-	1.00e-02	GO:0003433	chondrocyte development involved in endochondral bone morphogenesis	BP
1	1	6.64061170756	-	1.00e-02	GO:0044111	development involved in symbiotic interaction	BP
1	1	6.64061170756	-	1.00e-02	GO:0000414	regulation of histone H3-K36 methylation	BP
1	1	6.64061170756	-	1.00e-02	GO:0050865	regulation of cell activation	BP
1	1	6.64061170756	-	1.00e-02	GO:0002154	thyroid hormone mediated signaling pathway	BP
1	1	6.64061170756	-	1.00e-02	GO:0052547	regulation of peptidase activity	BP
1	1	6.64061170756	-	1.00e-02	GO:0072362	regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter	BP
1	1	6.64061170756	-	1.00e-02	GO:0072365	regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter	BP
1	1	6.64061170756	-	1.00e-02	GO:0071873	response to norepinephrine	BP
1	1	6.64061170756	-	1.00e-02	GO:0071250	cellular response to nitrite	BP
1	1	6.64061170756	-	1.00e-02	GO:0043049	otic placode formation	BP
1	1	6.64061170756	-	1.00e-02	GO:0045713	low-density lipoprotein particle receptor biosynthetic process	BP
1	1	6.64061170756	-	1.00e-02	GO:2000184	positive regulation of progesterone biosynthetic process	BP
1	1	6.64061170756	-	1.00e-02	GO:2000230	negative regulation of pancreatic stellate cell proliferation	BP
1	1	6.64061170756	-	1.00e-02	GO:0060694	regulation of cholesterol transporter activity	BP
1	1	6.64061170756	-	1.00e-02	GO:1901860	positive regulation of mitochondrial DNA metabolic process	BP
1	1	6.64061170756	-	1.00e-02	GO:1901863	positive regulation of muscle tissue development	BP
1	1	6.64061170756	-	1.00e-02	GO:0042501	serine phosphorylation of STAT protein	BP
3	3	6.64061170756	-	9.85e-07	GO:0004886	9-cis retinoic acid receptor activity	MF
2	2	6.64061170756	-	9.97e-05	GO:0034212	peptide N-acetyltransferase activity	MF
1	1	6.64061170756	-	1.00e-02	GO:0004955	prostaglandin receptor activity	MF
1	1	6.64061170756	-	1.00e-02	GO:0061733	peptide-lysine-N-acetyltransferase activity	MF
1	1	6.64061170756	-	1.00e-02	GO:0001010	transcription factor activity, sequence-specific DNA binding transcription factor recruiting	MF
1	1	6.64061170756	-	1.00e-02	GO:0043997	histone acetyltransferase activity (H4-K12 specific)	MF
1	1	6.64061170756	-	1.00e-02	GO:0061629	RNA polymerase II sequence-specific DNA binding transcription factor binding	MF
1	1	6.64061170756	-	1.00e-02	GO:0030549	acetylcholine receptor activator activity	MF
1	1	6.64061170756	-	1.00e-02	GO:1990188	euchromatin binding	MF
1	1	6.64061170756	-	1.00e-02	GO:0061656	SUMO conjugating enzyme activity	MF
1	1	6.64061170756	-	1.00e-02	GO:0004728	signal transducer, downstream of receptor, with protein tyrosine phosphatase activity	MF
1	1	6.64061170756	-	1.00e-02	GO:0070320	inward rectifier potassium channel inhibitor activity	MF
1	1	6.64061170756	-	1.00e-02	GO:0036403	arachidonate 8(S)-lipoxygenase activity	MF
1	1	6.64061170756	-	1.00e-02	GO:0032448	DNA hairpin binding	MF
1	1	6.64061170756	-	1.00e-02	GO:0035258	steroid hormone receptor binding	MF
1	1	6.64061170756	-	1.00e-02	GO:0050692	DBD domain binding	MF
2	3	6.05564920684	-	2.97e-04	GO:0070562	regulation of vitamin D receptor signaling pathway	BP
2	3	6.05564920684	-	2.97e-04	GO:0045604	regulation of epidermal cell differentiation	BP
2	3	6.05564920684	-	2.97e-04	GO:2001141	regulation of RNA biosynthetic process	BP
2	3	6.05564920684	-	2.97e-04	GO:0018076	N-terminal peptidyl-lysine acetylation	BP
2	3	6.05564920684	-	2.97e-04	GO:0021697	cerebellar cortex formation	BP
9	15	5.90364611339	-	5.25e-11	GO:0046965	retinoid X receptor binding	MF
4	8	5.64061170756	-	3.30e-07	GO:0035357	peroxisome proliferator activated receptor signaling pathway	BP
3	6	5.64061170756	-	1.93e-05	GO:0010742	macrophage derived foam cell differentiation	BP
2	4	5.64061170756	-	5.91e-04	GO:0035948	positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter	BP
2	4	5.64061170756	-	5.91e-04	GO:0033136	serine phosphorylation of STAT3 protein	BP
2	4	5.64061170756	-	5.91e-04	GO:0048679	regulation of axon regeneration	BP
1	2	5.64061170756	-	1.00e-02	GO:1901857	positive regulation of cellular respiration	BP
1	2	5.64061170756	-	1.00e-02	GO:0007423	sensory organ development	BP
1	2	5.64061170756	-	1.00e-02	GO:1901979	regulation of inward rectifier potassium channel activity	BP
1	2	5.64061170756	-	1.00e-02	GO:0030641	regulation of cellular pH	BP
1	2	5.64061170756	-	1.99e-02	GO:0090402	oncogene-induced cell senescence	BP
1	2	5.64061170756	-	1.99e-02	GO:0033144	negative regulation of intracellular steroid hormone receptor signaling pathway	BP
1	2	5.64061170756	-	1.99e-02	GO:0014740	negative regulation of muscle hyperplasia	BP
1	2	5.64061170756	-	1.99e-02	GO:2001055	positive regulation of mesenchymal cell apoptotic process	BP
1	2	5.64061170756	-	1.99e-02	GO:0071929	alpha-tubulin acetylation	BP
1	2	5.64061170756	-	1.99e-02	GO:0014040	positive regulation of Schwann cell differentiation	BP
1	2	5.64061170756	-	1.99e-02	GO:0021571	rhombomere 5 development	BP
1	2	5.64061170756	-	1.99e-02	GO:0071306	cellular response to vitamin E	BP
1	2	5.64061170756	-	1.99e-02	GO:0035947	regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter	BP
1	2	5.64061170756	-	1.99e-02	GO:2000327	positive regulation of ligand-dependent nuclear receptor transcription coactivator activity	BP
1	2	5.64061170756	-	1.99e-02	GO:0010874	regulation of cholesterol efflux	BP
1	2	5.64061170756	-	1.99e-02	GO:0048822	enucleate erythrocyte development	BP
1	2	5.64061170756	-	1.99e-02	GO:0044860	protein localization to plasma membrane raft	BP
1	2	5.64061170756	-	1.99e-02	GO:0035026	leading edge cell differentiation	BP
1	2	5.64061170756	-	1.99e-02	GO:1903894	regulation of IRE1-mediated unfolded protein response	BP
1	2	5.64061170756	-	1.99e-02	GO:0060502	epithelial cell proliferation involved in lung morphogenesis	BP
1	2	5.64061170756	-	1.99e-02	GO:0022037	metencephalon development	BP
1	2	5.64061170756	-	1.99e-02	GO:2000291	regulation of myoblast proliferation	BP
1	2	5.64061170756	-	1.99e-02	GO:0090427	activation of meiosis	BP
1	2	5.64061170756	-	1.99e-02	GO:2001038	regulation of cellular response to drug	BP
1	2	5.64061170756	-	1.99e-02	GO:0046619	optic placode formation involved in camera-type eye formation	BP
1	2	5.64061170756	-	1.99e-02	GO:0048513	animal organ development	BP
1	2	5.64061170756	-	1.99e-02	GO:0035408	histone H3-T6 phosphorylation	BP
1	2	5.64061170756	-	1.99e-02	GO:2000707	positive regulation of dense core granule biogenesis	BP
1	2	5.64061170756	-	1.99e-02	GO:0021986	habenula development	BP
1	2	5.64061170756	-	1.99e-02	GO:0045872	positive regulation of rhodopsin gene expression	BP
1	2	5.64061170756	-	1.99e-02	GO:0003057	regulation of the force of heart contraction by chemical signal	BP
1	2	5.64061170756	-	1.99e-02	GO:2000191	regulation of fatty acid transport	BP
1	2	5.64061170756	-	1.99e-02	GO:0021599	abducens nerve formation	BP
1	2	5.64061170756	-	1.99e-02	GO:0090149	mitochondrial membrane fission	BP
1	2	5.64061170756	-	1.99e-02	GO:0044154	histone H3-K14 acetylation	BP
1	2	5.64061170756	-	1.99e-02	GO:2000342	negative regulation of chemokine (C-X-C motif) ligand 2 production	BP
1	2	5.64061170756	-	1.99e-02	GO:0021514	ventral spinal cord interneuron differentiation	BP
1	2	5.64061170756	-	1.99e-02	GO:0033484	nitric oxide homeostasis	BP
1	2	5.64061170756	-	1.99e-02	GO:0072368	regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter	BP
1	2	5.64061170756	-	1.99e-02	GO:2000779	regulation of double-strand break repair	BP
1	2	5.64061170756	-	1.99e-02	GO:0060849	regulation of transcription involved in lymphatic endothelial cell fate commitment	BP
1	2	5.64061170756	-	1.99e-02	GO:0086098	angiotensin-activated signaling pathway involved in heart process	BP
1	2	5.64061170756	-	1.99e-02	GO:0060713	labyrinthine layer morphogenesis	BP
1	2	5.64061170756	-	1.99e-02	GO:0045994	positive regulation of translational initiation by iron	BP
10	20	5.64061170756	-	9.45e-12	GO:0016922	ligand-dependent nuclear receptor binding	MF
2	4	5.64061170756	-	5.91e-04	GO:0030375	thyroid hormone receptor coactivator activity	MF
2	4	5.64061170756	-	5.91e-04	GO:0071535	RING-like zinc finger domain binding	MF
2	4	5.64061170756	-	5.91e-04	GO:0050693	LBD domain binding	MF
1	2	5.64061170756	-	1.99e-02	GO:0033142	progesterone receptor binding	MF
1	2	5.64061170756	-	1.99e-02	GO:0016165	linoleate 13S-lipoxygenase activity	MF
1	2	5.64061170756	-	1.99e-02	GO:0035403	histone kinase activity (H3-T6 specific)	MF
1	2	5.64061170756	-	1.99e-02	GO:0035014	phosphatidylinositol 3-kinase regulator activity	MF
1	2	5.64061170756	-	1.99e-02	GO:0017129	triglyceride binding	MF
10	22	5.50310818381	-	2.36e-11	GO:0035257	nuclear hormone receptor binding	MF
3	7	5.41821928622	-	1.93e-05	GO:0071455	cellular response to hyperoxia	BP
5	12	5.37757730172	-	7.04e-08	GO:0042974	retinoic acid receptor binding	MF
2	5	5.31868361267	-	5.91e-04	GO:0003406	retinal pigment epithelium development	BP
2	5	5.31868361267	-	9.78e-04	GO:0060744	mammary gland branching involved in thelarche	BP
2	5	5.31868361267	-	9.78e-04	GO:0055012	ventricular cardiac muscle cell differentiation	BP
2	5	5.31868361267	-	9.78e-04	GO:0010606	positive regulation of cytoplasmic mRNA processing body assembly	BP
2	5	5.31868361267	-	9.78e-04	GO:0071376	cellular response to corticotropin-releasing hormone stimulus	BP
4	10	5.31868361267	-	1.94e-06	GO:0042975	peroxisome proliferator activated receptor binding	MF
2	5	5.31868361267	-	9.78e-04	GO:0003708	retinoic acid receptor activity	MF
6	16	5.22557420828	-	2.55e-09	GO:0048384	retinoic acid receptor signaling pathway	BP
2	6	5.05564920684	-	1.46e-03	GO:0046321	positive regulation of fatty acid oxidation	BP
2	6	5.05564920684	-	1.46e-03	GO:0030948	negative regulation of vascular endothelial growth factor receptor signaling pathway	BP
2	6	5.05564920684	-	1.46e-03	GO:1903799	negative regulation of production of miRNAs involved in gene silencing by miRNA	BP
2	6	5.05564920684	-	1.46e-03	GO:0031087	deadenylation-independent decapping of nuclear-transcribed mRNA	BP
2	6	5.05564920684	-	1.46e-03	GO:0051152	positive regulation of smooth muscle cell differentiation	BP
1	3	5.05564920684	-	1.99e-02	GO:0046885	regulation of hormone biosynthetic process	BP
1	3	5.05564920684	-	1.99e-02	GO:1902617	response to fluoride	BP
1	3	5.05564920684	-	1.99e-02	GO:0072136	metanephric mesenchymal cell proliferation involved in metanephros development	BP
1	3	5.05564920684	-	2.98e-02	GO:0034770	histone H4-K20 methylation	BP
1	3	5.05564920684	-	2.98e-02	GO:0055005	ventricular cardiac myofibril assembly	BP
1	3	5.05564920684	-	2.98e-02	GO:0006499	N-terminal protein myristoylation	BP
1	3	5.05564920684	-	2.98e-02	GO:0098903	regulation of membrane repolarization during action potential	BP
1	3	5.05564920684	-	2.98e-02	GO:0046985	positive regulation of hemoglobin biosynthetic process	BP
1	3	5.05564920684	-	2.98e-02	GO:0031587	positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity	BP
1	3	5.05564920684	-	2.98e-02	GO:0060414	aorta smooth muscle tissue morphogenesis	BP
1	3	5.05564920684	-	2.98e-02	GO:0007500	mesodermal cell fate determination	BP
1	3	5.05564920684	-	2.98e-02	GO:0033590	response to cobalamin	BP
1	3	5.05564920684	-	2.98e-02	GO:0055098	response to low-density lipoprotein particle	BP
1	3	5.05564920684	-	2.98e-02	GO:0072574	hepatocyte proliferation	BP
1	3	5.05564920684	-	2.98e-02	GO:0060745	mammary gland branching involved in pregnancy	BP
1	3	5.05564920684	-	2.98e-02	GO:1904798	positive regulation of core promoter binding	BP
1	3	5.05564920684	-	2.98e-02	GO:0035284	brain segmentation	BP
1	3	5.05564920684	-	2.98e-02	GO:0021885	forebrain cell migration	BP
1	3	5.05564920684	-	2.98e-02	GO:0010766	negative regulation of sodium ion transport	BP
1	3	5.05564920684	-	2.98e-02	GO:2000286	receptor internalization involved in canonical Wnt signaling pathway	BP
1	3	5.05564920684	-	2.98e-02	GO:0051795	positive regulation of timing of catagen	BP
1	3	5.05564920684	-	2.98e-02	GO:0045925	positive regulation of female receptivity	BP
1	3	5.05564920684	-	2.98e-02	GO:0035986	senescence-associated heterochromatin focus assembly	BP
1	3	5.05564920684	-	2.98e-02	GO:0010871	negative regulation of receptor biosynthetic process	BP
1	3	5.05564920684	-	2.98e-02	GO:0090043	regulation of tubulin deacetylation	BP
1	3	5.05564920684	-	2.98e-02	GO:0051365	cellular response to potassium ion starvation	BP
1	3	5.05564920684	-	2.98e-02	GO:1903421	regulation of synaptic vesicle recycling	BP
1	3	5.05564920684	-	2.98e-02	GO:0070966	nuclear-transcribed mRNA catabolic process, no-go decay	BP
1	3	5.05564920684	-	2.98e-02	GO:0003340	negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis	BP
1	3	5.05564920684	-	2.98e-02	GO:0042524	negative regulation of tyrosine phosphorylation of Stat5 protein	BP
1	3	5.05564920684	-	2.98e-02	GO:0035166	post-embryonic hemopoiesis	BP
1	3	5.05564920684	-	2.98e-02	GO:1903025	regulation of RNA polymerase II regulatory region sequence-specific DNA binding	BP
1	3	5.05564920684	-	2.98e-02	GO:1903598	positive regulation of gap junction assembly	BP
1	3	5.05564920684	-	2.98e-02	GO:0035880	embryonic nail plate morphogenesis	BP
1	3	5.05564920684	-	2.98e-02	GO:0034201	response to oleic acid	BP
1	3	5.05564920684	-	2.98e-02	GO:0090258	negative regulation of mitochondrial fission	BP
1	3	5.05564920684	-	2.98e-02	GO:1902593	single-organism nuclear import	BP
1	3	5.05564920684	-	2.98e-02	GO:2000630	positive regulation of miRNA metabolic process	BP
1	3	5.05564920684	-	2.98e-02	GO:0019065	receptor-mediated endocytosis of virus by host cell	BP
1	3	5.05564920684	-	2.98e-02	GO:0002068	glandular epithelial cell development	BP
1	3	5.05564920684	-	2.98e-02	GO:0071871	response to epinephrine	BP
1	3	5.05564920684	-	2.98e-02	GO:0071409	cellular response to cycloheximide	BP
1	3	5.05564920684	-	2.98e-02	GO:1904640	response to methionine	BP
2	6	5.05564920684	-	1.46e-03	GO:0001221	transcription cofactor binding	MF
1	3	5.05564920684	-	1.00e-02	GO:0033218	amide binding	MF
1	3	5.05564920684	-	1.99e-02	GO:0050473	arachidonate 15-lipoxygenase activity	MF
1	3	5.05564920684	-	2.98e-02	GO:0050816	phosphothreonine binding	MF
1	3	5.05564920684	-	2.98e-02	GO:0001012	RNA polymerase II regulatory region DNA binding	MF
1	3	5.05564920684	-	2.98e-02	GO:0070644	vitamin D response element binding	MF
1	3	5.05564920684	-	2.98e-02	GO:0010484	H3 histone acetyltransferase activity	MF
1	3	5.05564920684	-	2.98e-02	GO:0019166	trans-2-enoyl-CoA reductase (NADPH) activity	MF
1	3	5.05564920684	-	2.98e-02	GO:0050508	glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity	MF
1	3	5.05564920684	-	2.98e-02	GO:0008384	IkappaB kinase activity	MF
1	3	5.05564920684	-	2.98e-02	GO:0030348	syntaxin-3 binding	MF
1	3	5.05564920684	-	2.98e-02	GO:0043398	HLH domain binding	MF
12	40	4.90364611339	-	3.33e-11	GO:0044255	cellular lipid metabolic process	BP
8	27	4.88572420539	-	1.57e-10	GO:0046966	thyroid hormone receptor binding	MF
2	7	4.8332567855	-	1.46e-03	GO:0045722	positive regulation of gluconeogenesis	BP
2	7	4.8332567855	-	2.03e-03	GO:0042921	glucocorticoid receptor signaling pathway	BP
2	7	4.8332567855	-	2.03e-03	GO:0004887	thyroid hormone receptor activity	MF
3	11	4.76614258964	-	1.12e-04	GO:0006473	protein acetylation	BP
3	11	4.76614258964	-	1.12e-04	GO:0016407	acetyltransferase activity	MF
3	11	4.76614258964	-	1.53e-04	GO:0035259	glucocorticoid receptor binding	MF
10	39	4.67713758358	-	7.69e-11	GO:0030331	estrogen receptor binding	MF
3	12	4.64061170756	-	2.03e-04	GO:2000273	positive regulation of receptor activity	BP
1	4	4.64061170756	-	1.99e-02	GO:0060214	endocardium formation	BP
1	4	4.64061170756	-	2.98e-02	GO:0035616	histone H2B conserved C-terminal lysine deubiquitination	BP
1	4	4.64061170756	-	2.98e-02	GO:0031936	negative regulation of chromatin silencing	BP
1	4	4.64061170756	-	2.98e-02	GO:0070858	negative regulation of bile acid biosynthetic process	BP
1	4	4.64061170756	-	2.98e-02	GO:0060335	positive regulation of interferon-gamma-mediated signaling pathway	BP
1	4	4.64061170756	-	2.98e-02	GO:0007290	spermatid nucleus elongation	BP
1	4	4.64061170756	-	2.98e-02	GO:0048550	negative regulation of pinocytosis	BP
1	4	4.64061170756	-	3.95e-02	GO:0043201	response to leucine	BP
1	4	4.64061170756	-	3.95e-02	GO:0030578	PML body organization	BP
1	4	4.64061170756	-	3.95e-02	GO:0046545	development of primary female sexual characteristics	BP
1	4	4.64061170756	-	3.95e-02	GO:0014044	Schwann cell development	BP
1	4	4.64061170756	-	3.95e-02	GO:0032507	maintenance of protein location in cell	BP
1	4	4.64061170756	-	3.95e-02	GO:0045415	negative regulation of interleukin-8 biosynthetic process	BP
1	4	4.64061170756	-	3.95e-02	GO:0046602	regulation of mitotic centrosome separation	BP
1	4	4.64061170756	-	3.95e-02	GO:0060336	negative regulation of interferon-gamma-mediated signaling pathway	BP
1	4	4.64061170756	-	3.95e-02	GO:0050847	progesterone receptor signaling pathway	BP
1	4	4.64061170756	-	3.95e-02	GO:0060421	positive regulation of heart growth	BP
1	4	4.64061170756	-	3.95e-02	GO:0070318	positive regulation of G0 to G1 transition	BP
1	4	4.64061170756	-	3.95e-02	GO:0018393	internal peptidyl-lysine acetylation	BP
1	4	4.64061170756	-	3.95e-02	GO:0030910	olfactory placode formation	BP
1	4	4.64061170756	-	3.95e-02	GO:1990182	exosomal secretion	BP
1	4	4.64061170756	-	3.95e-02	GO:1903347	negative regulation of bicellular tight junction assembly	BP
1	4	4.64061170756	-	3.95e-02	GO:0090170	regulation of Golgi inheritance	BP
1	4	4.64061170756	-	3.95e-02	GO:1904504	positive regulation of lipophagy	BP
1	4	4.64061170756	-	3.95e-02	GO:0048386	positive regulation of retinoic acid receptor signaling pathway	BP
1	4	4.64061170756	-	3.95e-02	GO:0051660	establishment of centrosome localization	BP
1	4	4.64061170756	-	3.95e-02	GO:0032417	positive regulation of sodium:proton antiporter activity	BP
1	4	4.64061170756	-	3.95e-02	GO:0090240	positive regulation of histone H4 acetylation	BP
1	4	4.64061170756	-	3.95e-02	GO:0060364	frontal suture morphogenesis	BP
1	4	4.64061170756	-	3.95e-02	GO:0051169	nuclear transport	BP
1	4	4.64061170756	-	3.95e-02	GO:0010822	positive regulation of mitochondrion organization	BP
1	4	4.64061170756	-	3.95e-02	GO:0031077	post-embryonic camera-type eye development	BP
1	4	4.64061170756	-	3.95e-02	GO:0060298	positive regulation of sarcomere organization	BP
1	4	4.64061170756	-	3.95e-02	GO:0070836	caveola assembly	BP
1	4	4.64061170756	-	3.95e-02	GO:1904637	cellular response to ionomycin	BP
1	4	4.64061170756	-	3.95e-02	GO:0014878	response to electrical stimulus involved in regulation of muscle adaptation	BP
1	4	4.64061170756	-	3.95e-02	GO:0048549	positive regulation of pinocytosis	BP
1	4	4.64061170756	-	3.95e-02	GO:0003219	cardiac right ventricle formation	BP
1	4	4.64061170756	-	3.95e-02	GO:0002159	desmosome assembly	BP
1	4	4.64061170756	-	3.95e-02	GO:0002155	regulation of thyroid hormone mediated signaling pathway	BP
1	4	4.64061170756	-	3.95e-02	GO:0007100	mitotic centrosome separation	BP
1	4	4.64061170756	-	3.95e-02	GO:1901985	positive regulation of protein acetylation	BP
1	4	4.64061170756	-	3.95e-02	GO:0060355	positive regulation of cell adhesion molecule production	BP
1	4	4.64061170756	-	3.95e-02	GO:0051345	positive regulation of hydrolase activity	BP
1	4	4.64061170756	-	3.95e-02	GO:0030050	vesicle transport along actin filament	BP
1	4	4.64061170756	-	3.95e-02	GO:0060750	epithelial cell proliferation involved in mammary gland duct elongation	BP
1	4	4.64061170756	-	3.95e-02	GO:0006990	positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response	BP
1	4	4.64061170756	-	3.95e-02	GO:0060528	secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development	BP
1	4	4.64061170756	-	2.98e-02	GO:0044323	retinoic acid-responsive element binding	MF
1	4	4.64061170756	-	2.98e-02	GO:0005176	ErbB-2 class receptor binding	MF
1	4	4.64061170756	-	3.95e-02	GO:0050815	phosphoserine binding	MF
1	4	4.64061170756	-	3.95e-02	GO:0034056	estrogen response element binding	MF
1	4	4.64061170756	-	3.95e-02	GO:0036033	mediator complex binding	MF
1	4	4.64061170756	-	3.95e-02	GO:0001882	nucleoside binding	MF
1	4	4.64061170756	-	3.95e-02	GO:0043125	ErbB-3 class receptor binding	MF
1	4	4.64061170756	-	3.95e-02	GO:0004698	calcium-dependent protein kinase C activity	MF
1	4	4.64061170756	-	3.95e-02	GO:0031698	beta-2 adrenergic receptor binding	MF
10	41	4.60498779783	-	6.33e-12	GO:0050681	androgen receptor binding	MF
9	39	4.52513449014	-	1.29e-10	GO:0030522	intracellular receptor signaling pathway	BP
3	13	4.52513449014	-	1.12e-04	GO:0045618	positive regulation of keratinocyte differentiation	BP
3	13	4.52513449014	-	2.62e-04	GO:0001678	cellular glucose homeostasis	BP
8	35	4.51132869061	-	1.56e-09	GO:0004879	RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding	MF
12	53	4.49765375372	-	4.34e-11	GO:0003707	steroid hormone receptor activity	MF
11	49	4.48533348208	-	2.21e-11	GO:0030374	ligand-dependent nuclear receptor transcription coactivator activity	MF
12	54	4.47068670612	-	5.37e-11	GO:0043401	steroid hormone mediated signaling pathway	BP
2	9	4.47068670612	-	3.43e-03	GO:1901522	positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus	BP
2	9	4.47068670612	-	3.43e-03	GO:0007184	SMAD protein import into nucleus	BP
9	41	4.45298470438	-	1.65e-10	GO:0030521	androgen receptor signaling pathway	BP
2	10	4.31868361267	-	2.03e-03	GO:0015909	long-chain fatty acid transport	BP
1	5	4.31868361267	-	1.99e-02	GO:0070309	lens fiber cell morphogenesis	BP
1	5	4.31868361267	-	2.98e-02	GO:2000647	negative regulation of stem cell proliferation	BP
1	5	4.31868361267	-	2.98e-02	GO:1990845	adaptive thermogenesis	BP
1	5	4.31868361267	-	2.98e-02	GO:0030856	regulation of epithelial cell differentiation	BP
1	5	4.31868361267	-	3.95e-02	GO:0048730	epidermis morphogenesis	BP
1	5	4.31868361267	-	3.95e-02	GO:0003417	growth plate cartilage development	BP
1	5	4.31868361267	-	3.95e-02	GO:0072162	metanephric mesenchymal cell differentiation	BP
1	5	4.31868361267	-	3.95e-02	GO:0048311	mitochondrion distribution	BP
1	5	4.31868361267	-	3.95e-02	GO:0019217	regulation of fatty acid metabolic process	BP
1	5	4.31868361267	-	3.95e-02	GO:0031346	positive regulation of cell projection organization	BP
1	5	4.31868361267	-	3.95e-02	GO:0031914	negative regulation of synaptic plasticity	BP
1	5	4.31868361267	-	3.95e-02	GO:0051122	hepoxilin biosynthetic process	BP
1	5	4.31868361267	-	4.91e-02	GO:0060850	regulation of transcription involved in cell fate commitment	BP
1	5	4.31868361267	-	4.91e-02	GO:1902808	positive regulation of cell cycle G1/S phase transition	BP
1	5	4.31868361267	-	4.91e-02	GO:0030240	skeletal muscle thin filament assembly	BP
1	5	4.31868361267	-	4.91e-02	GO:0035509	negative regulation of myosin-light-chain-phosphatase activity	BP
1	5	4.31868361267	-	4.91e-02	GO:0065004	protein-DNA complex assembly	BP
1	5	4.31868361267	-	4.91e-02	GO:0031536	positive regulation of exit from mitosis	BP
1	5	4.31868361267	-	4.91e-02	GO:1990441	negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress	BP
1	5	4.31868361267	-	4.91e-02	GO:0060179	male mating behavior	BP
1	5	4.31868361267	-	4.91e-02	GO:0070431	nucleotide-binding oligomerization domain containing 2 signaling pathway	BP
1	5	4.31868361267	-	4.91e-02	GO:0034197	triglyceride transport	BP
1	5	4.31868361267	-	4.91e-02	GO:2001171	positive regulation of ATP biosynthetic process	BP
1	5	4.31868361267	-	4.91e-02	GO:0071332	cellular response to fructose stimulus	BP
1	5	4.31868361267	-	4.91e-02	GO:0072584	caveolin-mediated endocytosis	BP
1	5	4.31868361267	-	4.91e-02	GO:0033600	negative regulation of mammary gland epithelial cell proliferation	BP
1	5	4.31868361267	-	4.91e-02	GO:0060761	negative regulation of response to cytokine stimulus	BP
1	5	4.31868361267	-	4.91e-02	GO:0050713	negative regulation of interleukin-1 beta secretion	BP
1	5	4.31868361267	-	4.91e-02	GO:1903800	positive regulation of production of miRNAs involved in gene silencing by miRNA	BP
1	5	4.31868361267	-	4.91e-02	GO:0090330	regulation of platelet aggregation	BP
1	5	4.31868361267	-	4.91e-02	GO:2000535	regulation of entry of bacterium into host cell	BP
1	5	4.31868361267	-	4.91e-02	GO:0043550	regulation of lipid kinase activity	BP
1	5	4.31868361267	-	4.91e-02	GO:0010891	negative regulation of sequestering of triglyceride	BP
1	5	4.31868361267	-	4.91e-02	GO:0010452	histone H3-K36 methylation	BP
1	5	4.31868361267	-	4.91e-02	GO:0032534	regulation of microvillus assembly	BP
1	5	4.31868361267	-	4.91e-02	GO:1903361	protein localization to basolateral plasma membrane	BP
2	10	4.31868361267	-	2.68e-03	GO:0001206	transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding	MF
1	5	4.31868361267	-	3.95e-02	GO:0061665	SUMO ligase activity	MF
1	5	4.31868361267	-	3.95e-02	GO:0019871	sodium channel inhibitor activity	MF
1	5	4.31868361267	-	4.91e-02	GO:0000975	regulatory region DNA binding	MF
1	5	4.31868361267	-	4.91e-02	GO:0005324	long-chain fatty acid transporter activity	MF
1	5	4.31868361267	-	4.91e-02	GO:0050544	arachidonic acid binding	MF
1	5	4.31868361267	-	4.91e-02	GO:0004532	exoribonuclease activity	MF
1	5	4.31868361267	-	4.91e-02	GO:0042799	histone methyltransferase activity (H4-K20 specific)	MF
1	5	4.31868361267	-	4.91e-02	GO:0071532	ankyrin repeat binding	MF
1	5	4.31868361267	-	4.91e-02	GO:0043426	MRF binding	MF
3	16	4.22557420828	-	5.01e-04	GO:0030224	monocyte differentiation	BP
2	11	4.18118008892	-	1.46e-03	GO:0070166	enamel mineralization	BP
2	11	4.18118008892	-	4.26e-03	GO:0090051	negative regulation of cell migration involved in sprouting angiogenesis	BP
2	11	4.18118008892	-	5.17e-03	GO:1901653	cellular response to peptide	BP
2	11	4.18118008892	-	5.17e-03	GO:0035195	gene silencing by miRNA	BP
2	11	4.18118008892	-	5.17e-03	GO:0004707	MAP kinase activity	MF
3	17	4.13811136703	-	6.04e-04	GO:0042800	histone methyltransferase activity (H3-K4 specific)	MF
3	18	4.05564920684	-	7.20e-04	GO:0006337	nucleosome disassembly	BP
2	12	4.05564920684	-	4.26e-03	GO:0043616	keratinocyte proliferation	BP
2	12	4.05564920684	-	4.26e-03	GO:0042592	homeostatic process	BP
2	12	4.05564920684	-	5.17e-03	GO:0033147	negative regulation of intracellular estrogen receptor signaling pathway	BP
2	12	4.05564920684	-	6.16e-03	GO:0043149	stress fiber assembly	BP
2	12	4.05564920684	-	6.16e-03	GO:0032801	receptor catabolic process	BP
2	12	4.05564920684	-	6.16e-03	GO:0060444	branching involved in mammary gland duct morphogenesis	BP
1	6	4.05564920684	-	1.99e-02	GO:2000272	negative regulation of receptor activity	BP
1	6	4.05564920684	-	2.98e-02	GO:0051552	flavone metabolic process	BP
1	6	4.05564920684	-	2.98e-02	GO:0032964	collagen biosynthetic process	BP
1	6	4.05564920684	-	3.95e-02	GO:0045345	positive regulation of MHC class I biosynthetic process	BP
1	6	4.05564920684	-	3.95e-02	GO:0003416	endochondral bone growth	BP
1	6	4.05564920684	-	3.95e-02	GO:0009913	epidermal cell differentiation	BP
1	6	4.05564920684	-	3.95e-02	GO:2000507	positive regulation of energy homeostasis	BP
1	6	4.05564920684	-	4.91e-02	GO:0010887	negative regulation of cholesterol storage	BP
1	6	4.05564920684	-	4.91e-02	GO:0061469	regulation of type B pancreatic cell proliferation	BP
1	6	4.05564920684	-	4.91e-02	GO:0048845	venous blood vessel morphogenesis	BP
1	6	4.05564920684	-	4.91e-02	GO:0032792	negative regulation of CREB transcription factor activity	BP
1	6	4.05564920684	-	4.91e-02	GO:0060836	lymphatic endothelial cell differentiation	BP
1	6	4.05564920684	-	4.91e-02	GO:0033211	adiponectin-activated signaling pathway	BP
1	6	4.05564920684	-	4.91e-02	GO:0021796	cerebral cortex regionalization	BP
1	6	4.05564920684	-	4.91e-02	GO:0060056	mammary gland involution	BP
1	6	4.05564920684	-	5.87e-02	GO:0051271	negative regulation of cellular component movement	BP
1	6	4.05564920684	-	5.87e-02	GO:0043619	regulation of transcription from RNA polymerase II promoter in response to oxidative stress	BP
1	6	4.05564920684	-	5.87e-02	GO:0036003	positive regulation of transcription from RNA polymerase II promoter in response to stress	BP
1	6	4.05564920684	-	5.87e-02	GO:0010216	maintenance of DNA methylation	BP
1	6	4.05564920684	-	5.87e-02	GO:1903140	regulation of establishment of endothelial barrier	BP
1	6	4.05564920684	-	5.87e-02	GO:0060363	cranial suture morphogenesis	BP
1	6	4.05564920684	-	5.87e-02	GO:1901016	regulation of potassium ion transmembrane transporter activity	BP
1	6	4.05564920684	-	5.87e-02	GO:0033601	positive regulation of mammary gland epithelial cell proliferation	BP
1	6	4.05564920684	-	5.87e-02	GO:0035520	monoubiquitinated protein deubiquitination	BP
1	6	4.05564920684	-	5.87e-02	GO:0060762	regulation of branching involved in mammary gland duct morphogenesis	BP
1	6	4.05564920684	-	5.87e-02	GO:0045661	regulation of myoblast differentiation	BP
1	6	4.05564920684	-	5.87e-02	GO:0007182	common-partner SMAD protein phosphorylation	BP
1	6	4.05564920684	-	5.87e-02	GO:0071156	regulation of cell cycle arrest	BP
1	6	4.05564920684	-	5.87e-02	GO:0032873	negative regulation of stress-activated MAPK cascade	BP
1	6	4.05564920684	-	5.87e-02	GO:0061312	BMP signaling pathway involved in heart development	BP
1	6	4.05564920684	-	5.87e-02	GO:0045084	positive regulation of interleukin-12 biosynthetic process	BP
1	6	4.05564920684	-	5.87e-02	GO:0060440	trachea formation	BP
1	6	4.05564920684	-	5.87e-02	GO:0035897	proteolysis in other organism	BP
2	12	4.05564920684	-	6.16e-03	GO:0000983	transcription factor activity, RNA polymerase II core promoter sequence-specific	MF
1	6	4.05564920684	-	4.91e-02	GO:0004468	lysine N-acetyltransferase activity, acting on acetyl phosphate as donor	MF
1	6	4.05564920684	-	5.87e-02	GO:0046975	histone methyltransferase activity (H3-K36 specific)	MF
3	19	3.97764669484	-	8.49e-04	GO:0051568	histone H3-K4 methylation	BP
2	13	3.94017198942	-	6.16e-03	GO:0006622	protein targeting to lysosome	BP
2	13	3.94017198942	-	6.16e-03	GO:0019395	fatty acid oxidation	BP
2	13	3.94017198942	-	6.16e-03	GO:0010745	negative regulation of macrophage derived foam cell differentiation	BP
2	13	3.94017198942	-	7.24e-03	GO:0060334	regulation of interferon-gamma-mediated signaling pathway	BP
2	13	3.94017198942	-	6.16e-03	GO:0004535	poly(A)-specific ribonuclease activity	MF
3	20	3.90364611339	-	8.49e-04	GO:0033613	activating transcription factor binding	MF
6	41	3.86802220366	-	1.64e-06	GO:0004402	histone acetyltransferase activity	MF
2	14	3.8332567855	-	3.43e-03	GO:0021854	hypothalamus development	BP
2	14	3.8332567855	-	8.39e-03	GO:0097067	cellular response to thyroid hormone stimulus	BP
2	14	3.8332567855	-	8.39e-03	GO:0043923	positive regulation by host of viral transcription	BP
2	14	3.8332567855	-	8.39e-03	GO:0035729	cellular response to hepatocyte growth factor stimulus	BP
1	7	3.8332567855	-	1.00e-02	GO:0006766	vitamin metabolic process	BP
1	7	3.8332567855	-	3.95e-02	GO:0021516	dorsal spinal cord development	BP
1	7	3.8332567855	-	4.91e-02	GO:0033135	regulation of peptidyl-serine phosphorylation	BP
1	7	3.8332567855	-	5.87e-02	GO:2000650	negative regulation of sodium ion transmembrane transporter activity	BP
1	7	3.8332567855	-	5.87e-02	GO:0019048	modulation by virus of host morphology or physiology	BP
1	7	3.8332567855	-	5.87e-02	GO:0043576	regulation of respiratory gaseous exchange	BP
1	7	3.8332567855	-	5.87e-02	GO:0006475	internal protein amino acid acetylation	BP
1	7	3.8332567855	-	5.87e-02	GO:0021707	cerebellar granule cell differentiation	BP
1	7	3.8332567855	-	5.87e-02	GO:0051001	negative regulation of nitric-oxide synthase activity	BP
1	7	3.8332567855	-	5.87e-02	GO:0060042	retina morphogenesis in camera-type eye	BP
1	7	3.8332567855	-	5.87e-02	GO:0060576	intestinal epithelial cell development	BP
1	7	3.8332567855	-	5.87e-02	GO:0044539	long-chain fatty acid import	BP
1	7	3.8332567855	-	5.87e-02	GO:0007379	segment specification	BP
1	7	3.8332567855	-	5.87e-02	GO:0034372	very-low-density lipoprotein particle remodeling	BP
1	7	3.8332567855	-	5.87e-02	GO:0043551	regulation of phosphatidylinositol 3-kinase activity	BP
1	7	3.8332567855	-	5.87e-02	GO:0042297	vocal learning	BP
1	7	3.8332567855	-	5.87e-02	GO:0045617	negative regulation of keratinocyte differentiation	BP
1	7	3.8332567855	-	6.81e-02	GO:0055009	atrial cardiac muscle tissue morphogenesis	BP
1	7	3.8332567855	-	6.81e-02	GO:0045657	positive regulation of monocyte differentiation	BP
1	7	3.8332567855	-	6.81e-02	GO:2000641	regulation of early endosome to late endosome transport	BP
1	7	3.8332567855	-	6.81e-02	GO:0046826	negative regulation of protein export from nucleus	BP
1	7	3.8332567855	-	6.81e-02	GO:0071499	cellular response to laminar fluid shear stress	BP
1	7	3.8332567855	-	6.81e-02	GO:2000177	regulation of neural precursor cell proliferation	BP
1	7	3.8332567855	-	6.81e-02	GO:0034141	positive regulation of toll-like receptor 3 signaling pathway	BP
1	7	3.8332567855	-	6.81e-02	GO:1903071	positive regulation of ER-associated ubiquitin-dependent protein catabolic process	BP
1	7	3.8332567855	-	6.81e-02	GO:0034351	negative regulation of glial cell apoptotic process	BP
1	7	3.8332567855	-	6.81e-02	GO:0031340	positive regulation of vesicle fusion	BP
1	7	3.8332567855	-	6.81e-02	GO:0032966	negative regulation of collagen biosynthetic process	BP
1	7	3.8332567855	-	6.81e-02	GO:0035360	positive regulation of peroxisome proliferator activated receptor signaling pathway	BP
1	7	3.8332567855	-	6.81e-02	GO:0042178	xenobiotic catabolic process	BP
1	7	3.8332567855	-	6.81e-02	GO:0060008	Sertoli cell differentiation	BP
1	7	3.8332567855	-	6.81e-02	GO:0060687	regulation of branching involved in prostate gland morphogenesis	BP
1	7	3.8332567855	-	6.81e-02	GO:2000347	positive regulation of hepatocyte proliferation	BP
1	7	3.8332567855	-	6.81e-02	GO:0032872	regulation of stress-activated MAPK cascade	BP
1	7	3.8332567855	-	6.81e-02	GO:0070417	cellular response to cold	BP
1	7	3.8332567855	-	6.81e-02	GO:0043983	histone H4-K12 acetylation	BP
1	7	3.8332567855	-	6.81e-02	GO:2000144	positive regulation of DNA-templated transcription, initiation	BP
1	7	3.8332567855	-	6.81e-02	GO:0021952	central nervous system projection neuron axonogenesis	BP
1	7	3.8332567855	-	6.81e-02	GO:0097157	pre-mRNA intronic binding	MF
1	7	3.8332567855	-	6.81e-02	GO:0044389	ubiquitin-like protein ligase binding	MF
5	36	3.792614801	-	1.78e-05	GO:0071392	cellular response to estradiol stimulus	BP
2	15	3.73372111195	-	9.61e-03	GO:0006978	DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator	BP
2	15	3.73372111195	-	7.24e-03	GO:0019789	SUMO transferase activity	MF
2	15	3.73372111195	-	8.39e-03	GO:0000987	core promoter proximal region sequence-specific DNA binding	MF
2	15	3.73372111195	-	9.61e-03	GO:0042809	vitamin D receptor binding	MF
2	16	3.64061170756	-	8.39e-03	GO:0035855	megakaryocyte development	BP
2	16	3.64061170756	-	1.09e-02	GO:0035994	response to muscle stretch	BP
1	8	3.64061170756	-	4.91e-02	GO:0031666	positive regulation of lipopolysaccharide-mediated signaling pathway	BP
1	8	3.64061170756	-	4.91e-02	GO:0035865	cellular response to potassium ion	BP
1	8	3.64061170756	-	4.91e-02	GO:0071313	cellular response to caffeine	BP
1	8	3.64061170756	-	5.87e-02	GO:0060346	bone trabecula formation	BP
1	8	3.64061170756	-	5.87e-02	GO:0035137	hindlimb morphogenesis	BP
1	8	3.64061170756	-	5.87e-02	GO:1904948	midbrain dopaminergic neuron differentiation	BP
1	8	3.64061170756	-	5.87e-02	GO:0035767	endothelial cell chemotaxis	BP
1	8	3.64061170756	-	6.81e-02	GO:0098909	regulation of cardiac muscle cell action potential involved in regulation of contraction	BP
1	8	3.64061170756	-	6.81e-02	GO:0000012	single strand break repair	BP
1	8	3.64061170756	-	6.81e-02	GO:0003139	secondary heart field specification	BP
1	8	3.64061170756	-	6.81e-02	GO:0060020	Bergmann glial cell differentiation	BP
1	8	3.64061170756	-	6.81e-02	GO:0033629	negative regulation of cell adhesion mediated by integrin	BP
1	8	3.64061170756	-	6.81e-02	GO:0006356	regulation of transcription from RNA polymerase I promoter	BP
1	8	3.64061170756	-	6.81e-02	GO:0048312	intracellular distribution of mitochondria	BP
1	8	3.64061170756	-	6.81e-02	GO:0033993	response to lipid	BP
1	8	3.64061170756	-	6.81e-02	GO:1901380	negative regulation of potassium ion transmembrane transport	BP
1	8	3.64061170756	-	6.81e-02	GO:1901844	regulation of cell communication by electrical coupling involved in cardiac conduction	BP
1	8	3.64061170756	-	6.81e-02	GO:0030850	prostate gland development	BP
1	8	3.64061170756	-	6.81e-02	GO:1901409	positive regulation of phosphorylation of RNA polymerase II C-terminal domain	BP
1	8	3.64061170756	-	6.81e-02	GO:0060059	embryonic retina morphogenesis in camera-type eye	BP
1	8	3.64061170756	-	6.81e-02	GO:0071316	cellular response to nicotine	BP
1	8	3.64061170756	-	7.74e-02	GO:0060100	positive regulation of phagocytosis, engulfment	BP
1	8	3.64061170756	-	7.74e-02	GO:0007097	nuclear migration	BP
1	8	3.64061170756	-	7.74e-02	GO:0050687	negative regulation of defense response to virus	BP
1	8	3.64061170756	-	7.74e-02	GO:0006012	galactose metabolic process	BP
1	8	3.64061170756	-	7.74e-02	GO:0045647	negative regulation of erythrocyte differentiation	BP
1	8	3.64061170756	-	7.74e-02	GO:0075713	establishment of integrated proviral latency	BP
1	8	3.64061170756	-	7.74e-02	GO:0002674	negative regulation of acute inflammatory response	BP
1	8	3.64061170756	-	7.74e-02	GO:0006268	DNA unwinding involved in DNA replication	BP
1	8	3.64061170756	-	7.74e-02	GO:0010941	regulation of cell death	BP
1	8	3.64061170756	-	7.74e-02	GO:0001960	negative regulation of cytokine-mediated signaling pathway	BP
1	8	3.64061170756	-	7.74e-02	GO:0034115	negative regulation of heterotypic cell-cell adhesion	BP
1	8	3.64061170756	-	7.74e-02	GO:0007289	spermatid nucleus differentiation	BP
1	8	3.64061170756	-	7.74e-02	GO:1903599	positive regulation of mitophagy	BP
1	8	3.64061170756	-	7.74e-02	GO:0014732	skeletal muscle atrophy	BP
1	8	3.64061170756	-	7.74e-02	GO:2000774	positive regulation of cellular senescence	BP
1	8	3.64061170756	-	5.87e-02	GO:0001162	RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding	MF
1	8	3.64061170756	-	5.87e-02	GO:0032052	bile acid binding	MF
1	8	3.64061170756	-	6.81e-02	GO:0005113	patched binding	MF
1	8	3.64061170756	-	6.81e-02	GO:0102391	decanoate--CoA ligase activity	MF
1	8	3.64061170756	-	7.74e-02	GO:0032183	SUMO binding	MF
1	8	3.64061170756	-	7.74e-02	GO:0003680	AT DNA binding	MF
7	58	3.58998563449	-	9.15e-07	GO:0031490	chromatin DNA binding	MF
18	150	3.5817180185	-	2.03e-11	GO:0006367	transcription initiation from RNA polymerase II promoter	BP
3	25	3.5817180185	-	4.10e-04	GO:0015721	bile acid and bile salt transport	BP
3	25	3.5817180185	-	1.15e-03	GO:0016573	histone acetylation	BP
2	17	3.55314886631	-	8.39e-03	GO:0043651	linoleic acid metabolic process	BP
2	17	3.55314886631	-	8.39e-03	GO:0030301	cholesterol transport	BP
2	17	3.55314886631	-	9.61e-03	GO:0071354	cellular response to interleukin-6	BP
2	17	3.55314886631	-	9.61e-03	GO:0045956	positive regulation of calcium ion-dependent exocytosis	BP
2	17	3.55314886631	-	9.61e-03	GO:0048488	synaptic vesicle endocytosis	BP
2	17	3.55314886631	-	9.61e-03	GO:0021542	dentate gyrus development	BP
2	17	3.55314886631	-	9.61e-03	GO:0071375	cellular response to peptide hormone stimulus	BP
2	17	3.55314886631	-	9.61e-03	GO:0001190	transcriptional activator activity, RNA polymerase II transcription factor binding	MF
5	43	3.53627504774	-	6.67e-05	GO:1904837	beta-catenin-TCF complex assembly	BP
5	44	3.50310818381	-	4.67e-05	GO:0007519	skeletal muscle tissue development	BP
2	18	3.47068670612	-	1.23e-02	GO:0035066	positive regulation of histone acetylation	BP
1	9	3.47068670612	-	5.87e-02	GO:0055091	phospholipid homeostasis	BP
1	9	3.47068670612	-	6.81e-02	GO:0035313	wound healing, spreading of epidermal cells	BP
1	9	3.47068670612	-	7.74e-02	GO:0090197	positive regulation of chemokine secretion	BP
1	9	3.47068670612	-	7.74e-02	GO:1900027	regulation of ruffle assembly	BP
1	9	3.47068670612	-	7.74e-02	GO:0019953	sexual reproduction	BP
1	9	3.47068670612	-	7.74e-02	GO:0060674	placenta blood vessel development	BP
1	9	3.47068670612	-	7.74e-02	GO:0030857	negative regulation of epithelial cell differentiation	BP
1	9	3.47068670612	-	7.74e-02	GO:0003197	endocardial cushion development	BP
1	9	3.47068670612	-	7.74e-02	GO:1901223	negative regulation of NIK/NF-kappaB signaling	BP
1	9	3.47068670612	-	7.74e-02	GO:2000059	negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process	BP
1	9	3.47068670612	-	8.67e-02	GO:0010224	response to UV-B	BP
1	9	3.47068670612	-	8.67e-02	GO:0010761	fibroblast migration	BP
1	9	3.47068670612	-	8.67e-02	GO:0050807	regulation of synapse organization	BP
1	9	3.47068670612	-	8.67e-02	GO:0010944	negative regulation of transcription by competitive promoter binding	BP
1	9	3.47068670612	-	8.67e-02	GO:0033160	positive regulation of protein import into nucleus, translocation	BP
1	9	3.47068670612	-	8.67e-02	GO:0035456	response to interferon-beta	BP
1	9	3.47068670612	-	8.67e-02	GO:0032688	negative regulation of interferon-beta production	BP
1	9	3.47068670612	-	8.67e-02	GO:0032000	positive regulation of fatty acid beta-oxidation	BP
1	9	3.47068670612	-	8.67e-02	GO:0060711	labyrinthine layer development	BP
3	27	3.47068670612	-	2.16e-03	GO:0001205	transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding	MF
2	18	3.47068670612	-	4.26e-03	GO:0016409	palmitoyltransferase activity	MF
1	9	3.47068670612	-	7.74e-02	GO:0001191	transcriptional repressor activity, RNA polymerase II transcription factor binding	MF
1	9	3.47068670612	-	8.67e-02	GO:0043995	histone acetyltransferase activity (H4-K5 specific)	MF
1	9	3.47068670612	-	8.67e-02	GO:0043996	histone acetyltransferase activity (H4-K8 specific)	MF
1	9	3.47068670612	-	8.67e-02	GO:0046972	histone acetyltransferase activity (H4-K16 specific)	MF
1	9	3.47068670612	-	8.67e-02	GO:0001075	transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly	MF
1	9	3.47068670612	-	8.67e-02	GO:0005522	profilin binding	MF
1	9	3.47068670612	-	8.67e-02	GO:0045505	dynein intermediate chain binding	MF
3	28	3.41821928622	-	1.51e-03	GO:0035116	embryonic hindlimb morphogenesis	BP
2	19	3.39268419411	-	5.17e-03	GO:0018345	protein palmitoylation	BP
2	19	3.39268419411	-	1.37e-02	GO:0043153	entrainment of circadian clock by photoperiod	BP
2	19	3.39268419411	-	1.37e-02	GO:0030099	myeloid cell differentiation	BP
4	38	3.39268419411	-	4.44e-04	GO:0001102	RNA polymerase II activating transcription factor binding	MF
7	67	3.38187743916	-	3.36e-06	GO:0002039	p53 binding	MF
3	29	3.36759321315	-	2.69e-03	GO:0048662	negative regulation of smooth muscle cell proliferation	BP
7	69	3.33944217284	-	2.42e-06	GO:0045444	fat cell differentiation	BP
2	20	3.31868361267	-	6.16e-03	GO:0055074	calcium ion homeostasis	BP
2	20	3.31868361267	-	8.39e-03	GO:0001659	temperature homeostasis	BP
2	20	3.31868361267	-	1.37e-02	GO:0097150	neuronal stem cell population maintenance	BP
2	20	3.31868361267	-	1.37e-02	GO:0030520	intracellular estrogen receptor signaling pathway	BP
2	20	3.31868361267	-	1.68e-02	GO:1902895	positive regulation of pri-miRNA transcription from RNA polymerase II promoter	BP
1	10	3.31868361267	-	4.91e-02	GO:0046470	phosphatidylcholine metabolic process	BP
1	10	3.31868361267	-	4.91e-02	GO:0048387	negative regulation of retinoic acid receptor signaling pathway	BP
1	10	3.31868361267	-	5.87e-02	GO:0007567	parturition	BP
1	10	3.31868361267	-	5.87e-02	GO:0002021	response to dietary excess	BP
1	10	3.31868361267	-	6.81e-02	GO:0048935	peripheral nervous system neuron development	BP
1	10	3.31868361267	-	7.74e-02	GO:0033674	positive regulation of kinase activity	BP
1	10	3.31868361267	-	7.74e-02	GO:0022038	corpus callosum development	BP
1	10	3.31868361267	-	7.74e-02	GO:0031953	negative regulation of protein autophosphorylation	BP
1	10	3.31868361267	-	7.74e-02	GO:0048048	embryonic eye morphogenesis	BP
1	10	3.31868361267	-	8.67e-02	GO:0045475	locomotor rhythm	BP
1	10	3.31868361267	-	9.59e-02	GO:0051272	positive regulation of cellular component movement	BP
1	10	3.31868361267	-	9.59e-02	GO:0033148	positive regulation of intracellular estrogen receptor signaling pathway	BP
1	10	3.31868361267	-	9.59e-02	GO:0042053	regulation of dopamine metabolic process	BP
1	10	3.31868361267	-	9.59e-02	GO:0071383	cellular response to steroid hormone stimulus	BP
1	10	3.31868361267	-	9.59e-02	GO:0051247	positive regulation of protein metabolic process	BP
1	10	3.31868361267	-	9.59e-02	GO:0033235	positive regulation of protein sumoylation	BP
1	10	3.31868361267	-	9.59e-02	GO:0060546	negative regulation of necroptotic process	BP
1	10	3.31868361267	-	9.59e-02	GO:0071372	cellular response to follicle-stimulating hormone stimulus	BP
1	10	3.31868361267	-	9.59e-02	GO:0033327	Leydig cell differentiation	BP
1	10	3.31868361267	-	9.59e-02	GO:0014067	negative regulation of phosphatidylinositol 3-kinase signaling	BP
1	10	3.31868361267	-	9.59e-02	GO:0042416	dopamine biosynthetic process	BP
1	10	3.31868361267	-	9.59e-02	GO:0031000	response to caffeine	BP
1	10	3.31868361267	-	9.59e-02	GO:0000338	protein deneddylation	BP
4	40	3.31868361267	-	4.94e-04	GO:0018024	histone-lysine N-methyltransferase activity	MF
1	10	3.31868361267	-	8.67e-02	GO:0032454	histone demethylase activity (H3-K9 specific)	MF
1	10	3.31868361267	-	8.67e-02	GO:0016504	peptidase activator activity	MF
1	10	3.31868361267	-	9.59e-02	GO:0042805	actinin binding	MF
1	10	3.31868361267	-	9.59e-02	GO:0033558	protein deacetylase activity	MF
1	10	3.31868361267	-	9.59e-02	GO:0070016	armadillo repeat domain binding	MF
1	10	3.31868361267	-	9.59e-02	GO:0034452	dynactin binding	MF
24	243	3.30076170467	-	2.22e-11	GO:0003713	transcription coactivator activity	MF
2	21	3.24829428478	-	1.37e-02	GO:0035902	response to immobilization stress	BP
2	21	3.24829428478	-	1.68e-02	GO:0030879	mammary gland development	BP
3	32	3.22557420828	-	3.28e-03	GO:0043967	histone H4 acetylation	BP
4	43	3.21434695286	-	7.34e-04	GO:0001046	core promoter sequence-specific DNA binding	MF
7	76	3.20003911617	-	3.02e-06	GO:0007623	circadian rhythm	BP
4	44	3.18118008892	-	3.97e-04	GO:0032870	cellular response to hormone stimulus	BP
2	22	3.18118008892	-	1.09e-02	GO:0019915	lipid storage	BP
2	22	3.18118008892	-	1.68e-02	GO:0046329	negative regulation of JNK cascade	BP
2	22	3.18118008892	-	1.85e-02	GO:0003148	outflow tract septum morphogenesis	BP
1	11	3.18118008892	-	4.91e-02	GO:0006590	thyroid hormone generation	BP
1	11	3.18118008892	-	6.81e-02	GO:0006702	androgen biosynthetic process	BP
1	11	3.18118008892	-	6.81e-02	GO:0008406	gonad development	BP
1	11	3.18118008892	-	6.81e-02	GO:0042551	neuron maturation	BP
1	11	3.18118008892	-	7.74e-02	GO:0010524	positive regulation of calcium ion transport into cytosol	BP
1	11	3.18118008892	-	7.74e-02	GO:0006707	cholesterol catabolic process	BP
1	11	3.18118008892	-	7.74e-02	GO:0045446	endothelial cell differentiation	BP
1	11	3.18118008892	-	7.74e-02	GO:0060294	cilium movement involved in cell motility	BP
1	11	3.18118008892	-	8.67e-02	GO:0032703	negative regulation of interleukin-2 production	BP
1	11	3.18118008892	-	8.67e-02	GO:0001893	maternal placenta development	BP
1	11	3.18118008892	-	8.67e-02	GO:0070365	hepatocyte differentiation	BP
1	11	3.18118008892	-	8.67e-02	GO:0043666	regulation of phosphoprotein phosphatase activity	BP
1	11	3.18118008892	-	9.59e-02	GO:0071498	cellular response to fluid shear stress	BP
1	11	3.18118008892	-	9.59e-02	GO:2000036	regulation of stem cell population maintenance	BP
1	11	3.18118008892	-	9.59e-02	GO:0032206	positive regulation of telomere maintenance	BP
1	11	3.18118008892	-	9.59e-02	GO:0098911	regulation of ventricular cardiac muscle cell action potential	BP
1	11	3.18118008892	-	9.59e-02	GO:0030033	microvillus assembly	BP
1	11	3.18118008892	-	9.59e-02	GO:0006476	protein deacetylation	BP
1	11	3.18118008892	-	9.59e-02	GO:0033169	histone H3-K9 demethylation	BP
1	11	3.18118008892	-	9.59e-02	GO:0060213	positive regulation of nuclear-transcribed mRNA poly(A) tail shortening	BP
1	11	3.18118008892	-	9.59e-02	GO:0021756	striatum development	BP
1	11	3.18118008892	-	9.59e-02	GO:0008610	lipid biosynthetic process	BP
1	11	3.18118008892	-	1.05e-01	GO:0042347	negative regulation of NF-kappaB import into nucleus	BP
1	11	3.18118008892	-	1.05e-01	GO:0030238	male sex determination	BP
1	11	3.18118008892	-	1.05e-01	GO:0032495	response to muramyl dipeptide	BP
1	11	3.18118008892	-	1.05e-01	GO:0035970	peptidyl-threonine dephosphorylation	BP
1	11	3.18118008892	-	1.05e-01	GO:0060765	regulation of androgen receptor signaling pathway	BP
1	11	3.18118008892	-	1.05e-01	GO:0061001	regulation of dendritic spine morphogenesis	BP
1	11	3.18118008892	-	7.74e-02	GO:0042301	phosphate ion binding	MF
1	11	3.18118008892	-	8.67e-02	GO:0005548	phospholipid transporter activity	MF
1	11	3.18118008892	-	9.59e-02	GO:0001223	transcription coactivator binding	MF
1	11	3.18118008892	-	1.05e-01	GO:0032041	NAD-dependent histone deacetylase activity (H3-K14 specific)	MF
3	33	3.18118008892	-	3.95e-03	GO:0001104	RNA polymerase II transcription cofactor activity	MF
25	278	3.16552682461	-	1.99e-11	GO:0008134	transcription factor binding	MF
2	23	3.1170497515	-	1.53e-02	GO:0055088	lipid homeostasis	BP
2	23	3.1170497515	-	1.85e-02	GO:0070371	ERK1 and ERK2 cascade	BP
2	23	3.1170497515	-	2.02e-02	GO:0090398	cellular senescence	BP
2	23	3.1170497515	-	2.20e-02	GO:0030866	cortical actin cytoskeleton organization	BP
3	35	3.09629119133	-	3.95e-03	GO:0006641	triglyceride metabolic process	BP
3	35	3.09629119133	-	4.31e-03	GO:0045786	negative regulation of cell cycle	BP
5	60	3.05564920684	-	2.59e-04	GO:0006977	DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest	BP
2	24	3.05564920684	-	2.02e-02	GO:0055007	cardiac muscle cell differentiation	BP
2	24	3.05564920684	-	2.38e-02	GO:2001238	positive regulation of extrinsic apoptotic signaling pathway	BP
1	12	3.05564920684	-	6.81e-02	GO:0042574	retinal metabolic process	BP
1	12	3.05564920684	-	7.74e-02	GO:0034374	low-density lipoprotein particle remodeling	BP
1	12	3.05564920684	-	8.67e-02	GO:0007041	lysosomal transport	BP
1	12	3.05564920684	-	9.59e-02	GO:0021846	cell proliferation in forebrain	BP
1	12	3.05564920684	-	9.59e-02	GO:0071391	cellular response to estrogen stimulus	BP
1	12	3.05564920684	-	1.05e-01	GO:0001946	lymphangiogenesis	BP
1	12	3.05564920684	-	1.05e-01	GO:0043922	negative regulation by host of viral transcription	BP
1	12	3.05564920684	-	1.05e-01	GO:2000505	regulation of energy homeostasis	BP
1	12	3.05564920684	-	1.05e-01	GO:0071360	cellular response to exogenous dsRNA	BP
1	12	3.05564920684	-	1.14e-01	GO:0021819	layer formation in cerebral cortex	BP
1	12	3.05564920684	-	1.14e-01	GO:0047496	vesicle transport along microtubule	BP
1	12	3.05564920684	-	1.14e-01	GO:0045724	positive regulation of cilium assembly	BP
1	12	3.05564920684	-	1.14e-01	GO:0007252	I-kappaB phosphorylation	BP
1	12	3.05564920684	-	1.14e-01	GO:0051457	maintenance of protein location in nucleus	BP
1	12	3.05564920684	-	1.14e-01	GO:0045019	negative regulation of nitric oxide biosynthetic process	BP
1	12	3.05564920684	-	1.14e-01	GO:0003198	epithelial to mesenchymal transition involved in endocardial cushion formation	BP
1	12	3.05564920684	-	1.14e-01	GO:0060644	mammary gland epithelial cell differentiation	BP
1	12	3.05564920684	-	1.14e-01	GO:0016578	histone deubiquitination	BP
1	12	3.05564920684	-	1.14e-01	GO:0061014	positive regulation of mRNA catabolic process	BP
1	12	3.05564920684	-	1.14e-01	GO:0061099	negative regulation of protein tyrosine kinase activity	BP
1	12	3.05564920684	-	1.14e-01	GO:0045820	negative regulation of glycolytic process	BP
1	12	3.05564920684	-	1.14e-01	GO:0021954	central nervous system neuron development	BP
1	12	3.05564920684	-	9.59e-02	GO:0003906	DNA-(apurinic or apyrimidinic site) lyase activity	MF
1	12	3.05564920684	-	1.05e-01	GO:0050321	tau-protein kinase activity	MF
1	12	3.05564920684	-	1.14e-01	GO:0004708	MAP kinase kinase activity	MF
1	12	3.05564920684	-	1.14e-01	GO:0043422	protein kinase B binding	MF
1	12	3.05564920684	-	1.14e-01	GO:0000989	transcription factor activity, transcription factor binding	MF
4	49	3.02590186344	-	1.14e-03	GO:0042752	regulation of circadian rhythm	BP
2	25	2.99675551778	-	1.09e-02	GO:0006694	steroid biosynthetic process	BP
2	25	2.99675551778	-	1.68e-02	GO:0051899	membrane depolarization	BP
2	25	2.99675551778	-	2.38e-02	GO:0055010	ventricular cardiac muscle tissue morphogenesis	BP
2	25	2.99675551778	-	2.38e-02	GO:0045737	positive regulation of cyclin-dependent protein serine/threonine kinase activity	BP
5	63	2.98525987895	-	1.83e-04	GO:0043627	response to estrogen	BP
8	102	2.96818636559	-	7.12e-06	GO:0042826	histone deacetylase binding	MF
9	116	2.95255571387	-	8.88e-07	GO:0001078	transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding	MF
2	26	2.94017198942	-	2.77e-02	GO:0051225	spindle assembly	BP
1	13	2.94017198942	-	6.81e-02	GO:0021527	spinal cord association neuron differentiation	BP
1	13	2.94017198942	-	8.67e-02	GO:0005513	detection of calcium ion	BP
1	13	2.94017198942	-	8.67e-02	GO:0072001	renal system development	BP
1	13	2.94017198942	-	1.05e-01	GO:0050806	positive regulation of synaptic transmission	BP
1	13	2.94017198942	-	1.05e-01	GO:0061029	eyelid development in camera-type eye	BP
1	13	2.94017198942	-	1.05e-01	GO:0050872	white fat cell differentiation	BP
1	13	2.94017198942	-	1.05e-01	GO:0036109	alpha-linolenic acid metabolic process	BP
1	13	2.94017198942	-	1.05e-01	GO:0031641	regulation of myelination	BP
1	13	2.94017198942	-	1.14e-01	GO:0045651	positive regulation of macrophage differentiation	BP
1	13	2.94017198942	-	1.14e-01	GO:0051974	negative regulation of telomerase activity	BP
1	13	2.94017198942	-	1.14e-01	GO:1901224	positive regulation of NIK/NF-kappaB signaling	BP
1	13	2.94017198942	-	1.14e-01	GO:0010952	positive regulation of peptidase activity	BP
1	13	2.94017198942	-	1.14e-01	GO:1902166	negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	BP
1	13	2.94017198942	-	1.23e-01	GO:1900025	negative regulation of substrate adhesion-dependent cell spreading	BP
1	13	2.94017198942	-	1.23e-01	GO:2001234	negative regulation of apoptotic signaling pathway	BP
1	13	2.94017198942	-	1.23e-01	GO:0035418	protein localization to synapse	BP
1	13	2.94017198942	-	1.23e-01	GO:0048821	erythrocyte development	BP
1	13	2.94017198942	-	1.23e-01	GO:0043984	histone H4-K16 acetylation	BP
1	13	2.94017198942	-	9.59e-02	GO:0004467	long-chain fatty acid-CoA ligase activity	MF
1	13	2.94017198942	-	1.23e-01	GO:0035497	cAMP response element binding	MF
6	79	2.9217934601	-	9.63e-05	GO:0008013	beta-catenin binding	MF
5	66	2.91814568309	-	4.15e-04	GO:0000980	RNA polymerase II distal enhancer sequence-specific DNA binding	MF
3	40	2.90364611339	-	4.31e-03	GO:0032570	response to progesterone	BP
2	27	2.88572420539	-	2.57e-02	GO:0051090	regulation of sequence-specific DNA binding transcription factor activity	BP
2	27	2.88572420539	-	9.61e-03	GO:0019706	protein-cysteine S-palmitoyltransferase activity	MF
3	41	2.86802220366	-	6.43e-03	GO:0007595	lactation	BP
7	96	2.86300412889	-	4.63e-05	GO:0047485	protein N-terminus binding	MF
4	55	2.85925199403	-	1.68e-03	GO:0003712	transcription cofactor activity	MF
4	56	2.8332567855	-	2.22e-03	GO:0032922	circadian regulation of gene expression	BP
3	42	2.8332567855	-	4.70e-03	GO:0032526	response to retinoic acid	BP
2	28	2.8332567855	-	2.57e-02	GO:0001937	negative regulation of endothelial cell proliferation	BP
1	14	2.8332567855	-	8.67e-02	GO:0051604	protein maturation	BP
1	14	2.8332567855	-	9.59e-02	GO:0010839	negative regulation of keratinocyte proliferation	BP
1	14	2.8332567855	-	9.59e-02	GO:0031103	axon regeneration	BP
1	14	2.8332567855	-	9.59e-02	GO:0002063	chondrocyte development	BP
1	14	2.8332567855	-	1.05e-01	GO:0003407	neural retina development	BP
1	14	2.8332567855	-	1.14e-01	GO:0050965	detection of temperature stimulus involved in sensory perception of pain	BP
1	14	2.8332567855	-	1.14e-01	GO:0006359	regulation of transcription from RNA polymerase III promoter	BP
1	14	2.8332567855	-	1.14e-01	GO:0043409	negative regulation of MAPK cascade	BP
1	14	2.8332567855	-	1.14e-01	GO:0010832	negative regulation of myotube differentiation	BP
1	14	2.8332567855	-	1.14e-01	GO:0060038	cardiac muscle cell proliferation	BP
1	14	2.8332567855	-	1.14e-01	GO:2000310	regulation of NMDA receptor activity	BP
1	14	2.8332567855	-	1.14e-01	GO:0030517	negative regulation of axon extension	BP
1	14	2.8332567855	-	1.14e-01	GO:0042325	regulation of phosphorylation	BP
1	14	2.8332567855	-	1.14e-01	GO:1900153	positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay	BP
1	14	2.8332567855	-	1.14e-01	GO:2000678	negative regulation of transcription regulatory region DNA binding	BP
1	14	2.8332567855	-	1.23e-01	GO:0014912	negative regulation of smooth muscle cell migration	BP
1	14	2.8332567855	-	1.23e-01	GO:0060749	mammary gland alveolus development	BP
1	14	2.8332567855	-	1.23e-01	GO:0006940	regulation of smooth muscle contraction	BP
1	14	2.8332567855	-	1.23e-01	GO:0001817	regulation of cytokine production	BP
1	14	2.8332567855	-	1.23e-01	GO:0042692	muscle cell differentiation	BP
1	14	2.8332567855	-	1.23e-01	GO:0050892	intestinal absorption	BP
1	14	2.8332567855	-	1.32e-01	GO:0001774	microglial cell activation	BP
1	14	2.8332567855	-	1.32e-01	GO:0008631	intrinsic apoptotic signaling pathway in response to oxidative stress	BP
1	14	2.8332567855	-	1.32e-01	GO:0042953	lipoprotein transport	BP
1	14	2.8332567855	-	1.32e-01	GO:0042993	positive regulation of transcription factor import into nucleus	BP
1	14	2.8332567855	-	1.32e-01	GO:0022904	respiratory electron transport chain	BP
2	28	2.8332567855	-	3.18e-02	GO:0051059	NF-kappaB binding	MF
1	14	2.8332567855	-	1.14e-01	GO:0005504	fatty acid binding	MF
1	14	2.8332567855	-	1.14e-01	GO:0000982	transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding	MF
1	14	2.8332567855	-	1.23e-01	GO:0016538	cyclin-dependent protein serine/threonine kinase regulator activity	MF
1	14	2.8332567855	-	1.32e-01	GO:0031432	titin binding	MF
1	14	2.8332567855	-	1.32e-01	GO:0070063	RNA polymerase binding	MF
4	57	2.80772169339	-	1.80e-03	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	MF
3	43	2.79930945358	-	6.43e-03	GO:0048538	thymus development	BP
3	43	2.79930945358	-	9.07e-03	GO:0034644	cellular response to UV	BP
2	29	2.78263071243	-	2.02e-02	GO:0002088	lens development in camera-type eye	BP
2	29	2.78263071243	-	3.18e-02	GO:0000289	nuclear-transcribed mRNA poly(A) tail shortening	BP
2	29	2.78263071243	-	3.39e-02	GO:0042771	intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	BP
4	59	2.7579686582	-	2.70e-03	GO:0043433	negative regulation of sequence-specific DNA binding transcription factor activity	BP
4	60	2.73372111195	-	2.53e-03	GO:0070301	cellular response to hydrogen peroxide	BP
2	30	2.73372111195	-	2.38e-02	GO:0030901	midbrain development	BP
2	30	2.73372111195	-	2.57e-02	GO:0031667	response to nutrient levels	BP
2	30	2.73372111195	-	2.97e-02	GO:0007259	JAK-STAT cascade	BP
2	30	2.73372111195	-	3.18e-02	GO:0090503	RNA phosphodiester bond hydrolysis, exonucleolytic	BP
1	15	2.73372111195	-	8.67e-02	GO:0001963	synaptic transmission, dopaminergic	BP
1	15	2.73372111195	-	1.14e-01	GO:0035050	embryonic heart tube development	BP
1	15	2.73372111195	-	1.23e-01	GO:0002042	cell migration involved in sprouting angiogenesis	BP
1	15	2.73372111195	-	1.23e-01	GO:0044849	estrous cycle	BP
1	15	2.73372111195	-	1.23e-01	GO:0034375	high-density lipoprotein particle remodeling	BP
1	15	2.73372111195	-	1.32e-01	GO:0032469	endoplasmic reticulum calcium ion homeostasis	BP
1	15	2.73372111195	-	1.32e-01	GO:2000251	positive regulation of actin cytoskeleton reorganization	BP
1	15	2.73372111195	-	1.32e-01	GO:0010608	posttranscriptional regulation of gene expression	BP
1	15	2.73372111195	-	1.32e-01	GO:0000729	DNA double-strand break processing	BP
1	15	2.73372111195	-	1.32e-01	GO:0043162	ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway	BP
1	15	2.73372111195	-	1.32e-01	GO:0035458	cellular response to interferon-beta	BP
1	15	2.73372111195	-	1.32e-01	GO:0035024	negative regulation of Rho protein signal transduction	BP
1	15	2.73372111195	-	1.32e-01	GO:0070498	interleukin-1-mediated signaling pathway	BP
1	15	2.73372111195	-	1.40e-01	GO:0046328	regulation of JNK cascade	BP
1	15	2.73372111195	-	1.40e-01	GO:1902187	negative regulation of viral release from host cell	BP
1	15	2.73372111195	-	1.40e-01	GO:0051123	RNA polymerase II transcriptional preinitiation complex assembly	BP
1	15	2.73372111195	-	1.40e-01	GO:2000679	positive regulation of transcription regulatory region DNA binding	BP
1	15	2.73372111195	-	1.40e-01	GO:0043982	histone H4-K8 acetylation	BP
1	15	2.73372111195	-	1.40e-01	GO:0043981	histone H4-K5 acetylation	BP
1	15	2.73372111195	-	1.40e-01	GO:0051393	alpha-actinin binding	MF
1	15	2.73372111195	-	1.40e-01	GO:0004697	protein kinase C activity	MF
3	45	2.73372111195	-	5.97e-03	GO:0035914	skeletal muscle cell differentiation	BP
3	45	2.73372111195	-	9.07e-03	GO:0031100	animal organ regeneration	BP
3	46	2.70201225222	-	7.42e-03	GO:0051591	response to cAMP	BP
2	31	2.68641539717	-	2.38e-02	GO:0035115	embryonic forelimb morphogenesis	BP
3	47	2.6709853566	-	8.50e-03	GO:0000976	transcription regulatory region sequence-specific DNA binding	MF
3	48	2.64061170756	-	9.07e-03	GO:0034097	response to cytokine	BP
2	32	2.64061170756	-	3.61e-02	GO:0070555	response to interleukin-1	BP
2	32	2.64061170756	-	3.84e-02	GO:0042594	response to starvation	BP
1	16	2.64061170756	-	9.59e-02	GO:0008209	androgen metabolic process	BP
1	16	2.64061170756	-	1.05e-01	GO:0048566	embryonic digestive tract development	BP
1	16	2.64061170756	-	1.14e-01	GO:0019372	lipoxygenase pathway	BP
1	16	2.64061170756	-	1.23e-01	GO:0021522	spinal cord motor neuron differentiation	BP
1	16	2.64061170756	-	1.23e-01	GO:0014850	response to muscle activity	BP
1	16	2.64061170756	-	1.23e-01	GO:0048714	positive regulation of oligodendrocyte differentiation	BP
1	16	2.64061170756	-	1.23e-01	GO:0070509	calcium ion import	BP
1	16	2.64061170756	-	1.32e-01	GO:0031293	membrane protein intracellular domain proteolysis	BP
1	16	2.64061170756	-	1.32e-01	GO:0001709	cell fate determination	BP
1	16	2.64061170756	-	1.32e-01	GO:0003222	ventricular trabecula myocardium morphogenesis	BP
1	16	2.64061170756	-	1.40e-01	GO:2000811	negative regulation of anoikis	BP
1	16	2.64061170756	-	1.40e-01	GO:2000179	positive regulation of neural precursor cell proliferation	BP
1	16	2.64061170756	-	1.40e-01	GO:0035162	embryonic hemopoiesis	BP
1	16	2.64061170756	-	1.40e-01	GO:0043968	histone H2A acetylation	BP
1	16	2.64061170756	-	1.40e-01	GO:0071732	cellular response to nitric oxide	BP
1	16	2.64061170756	-	1.40e-01	GO:0010744	positive regulation of macrophage derived foam cell differentiation	BP
1	16	2.64061170756	-	1.49e-01	GO:0010613	positive regulation of cardiac muscle hypertrophy	BP
1	16	2.64061170756	-	1.49e-01	GO:0032270	positive regulation of cellular protein metabolic process	BP
1	16	2.64061170756	-	1.49e-01	GO:0030518	intracellular steroid hormone receptor signaling pathway	BP
1	16	2.64061170756	-	1.49e-01	GO:0000132	establishment of mitotic spindle orientation	BP
1	16	2.64061170756	-	1.49e-01	GO:0007020	microtubule nucleation	BP
2	32	2.64061170756	-	4.07e-02	GO:0070491	repressing transcription factor binding	MF
1	16	2.64061170756	-	1.32e-01	GO:0008574	ATP-dependent microtubule motor activity, plus-end-directed	MF
1	16	2.64061170756	-	1.49e-01	GO:0050750	low-density lipoprotein particle receptor binding	MF
1	16	2.64061170756	-	1.49e-01	GO:0050998	nitric-oxide synthase binding	MF
2	33	2.5962175882	-	3.39e-02	GO:0002931	response to ischemia	BP
2	33	2.5962175882	-	4.07e-02	GO:0051973	positive regulation of telomerase activity	BP
30	496	2.59330599278	-	2.66e-11	GO:0045893	positive regulation of transcription, DNA-templated	BP
3	50	2.5817180185	-	1.30e-02	GO:0032481	positive regulation of type I interferon production	BP
2	34	2.55314886631	-	3.39e-02	GO:0048813	dendrite morphogenesis	BP
1	17	2.55314886631	-	7.74e-02	GO:0050908	detection of light stimulus involved in visual perception	BP
1	17	2.55314886631	-	9.59e-02	GO:0015012	heparan sulfate proteoglycan biosynthetic process	BP
1	17	2.55314886631	-	1.05e-01	GO:0042310	vasoconstriction	BP
1	17	2.55314886631	-	1.23e-01	GO:0048514	blood vessel morphogenesis	BP
1	17	2.55314886631	-	1.32e-01	GO:0021537	telencephalon development	BP
1	17	2.55314886631	-	1.32e-01	GO:0032331	negative regulation of chondrocyte differentiation	BP
1	17	2.55314886631	-	1.32e-01	GO:0030193	regulation of blood coagulation	BP
1	17	2.55314886631	-	1.32e-01	GO:0042462	eye photoreceptor cell development	BP
1	17	2.55314886631	-	1.32e-01	GO:2000377	regulation of reactive oxygen species metabolic process	BP
1	17	2.55314886631	-	1.40e-01	GO:0071380	cellular response to prostaglandin E stimulus	BP
1	17	2.55314886631	-	1.40e-01	GO:0043691	reverse cholesterol transport	BP
1	17	2.55314886631	-	1.40e-01	GO:0045926	negative regulation of growth	BP
1	17	2.55314886631	-	1.49e-01	GO:0030325	adrenal gland development	BP
1	17	2.55314886631	-	1.49e-01	GO:0033189	response to vitamin A	BP
1	17	2.55314886631	-	1.49e-01	GO:1904355	positive regulation of telomere capping	BP
1	17	2.55314886631	-	1.49e-01	GO:0043536	positive regulation of blood vessel endothelial cell migration	BP
1	17	2.55314886631	-	1.49e-01	GO:0032418	lysosome localization	BP
1	17	2.55314886631	-	1.49e-01	GO:0048814	regulation of dendrite morphogenesis	BP
1	17	2.55314886631	-	1.49e-01	GO:0016571	histone methylation	BP
1	17	2.55314886631	-	1.49e-01	GO:0042789	mRNA transcription from RNA polymerase II promoter	BP
1	17	2.55314886631	-	1.57e-01	GO:0031333	negative regulation of protein complex assembly	BP
1	17	2.55314886631	-	1.23e-01	GO:0008301	DNA binding, bending	MF
1	17	2.55314886631	-	1.23e-01	GO:0017049	GTP-Rho binding	MF
1	17	2.55314886631	-	1.23e-01	GO:0017127	cholesterol transporter activity	MF
1	17	2.55314886631	-	1.57e-01	GO:0071837	HMG box domain binding	MF
4	69	2.53208725078	-	3.44e-03	GO:0001938	positive regulation of endothelial cell proliferation	BP
12	208	2.52513449014	-	6.29e-07	GO:0044212	transcription regulatory region DNA binding	MF
4	70	2.51132869061	-	3.86e-03	GO:0001889	liver development	BP
2	35	2.51132869061	-	4.30e-02	GO:0001105	RNA polymerase II transcription coactivator activity	MF
3	53	2.49765375372	-	1.23e-02	GO:0048511	rhythmic process	BP
1	18	2.47068670612	-	9.59e-02	GO:0023019	signal transduction involved in regulation of gene expression	BP
1	18	2.47068670612	-	1.32e-01	GO:1903861	positive regulation of dendrite extension	BP
1	18	2.47068670612	-	1.32e-01	GO:0035249	synaptic transmission, glutamatergic	BP
1	18	2.47068670612	-	1.40e-01	GO:0002076	osteoblast development	BP
1	18	2.47068670612	-	1.40e-01	GO:1903506	regulation of nucleic acid-templated transcription	BP
1	18	2.47068670612	-	1.40e-01	GO:0060324	face development	BP
1	18	2.47068670612	-	1.40e-01	GO:0016079	synaptic vesicle exocytosis	BP
1	18	2.47068670612	-	1.49e-01	GO:0010971	positive regulation of G2/M transition of mitotic cell cycle	BP
1	18	2.47068670612	-	1.57e-01	GO:0001892	embryonic placenta development	BP
1	18	2.47068670612	-	1.57e-01	GO:0008045	motor neuron axon guidance	BP
1	18	2.47068670612	-	1.66e-01	GO:0006913	nucleocytoplasmic transport	BP
1	18	2.47068670612	-	1.66e-01	GO:0031668	cellular response to extracellular stimulus	BP
1	18	2.47068670612	-	7.74e-02	GO:0004745	retinol dehydrogenase activity	MF
1	18	2.47068670612	-	1.14e-01	GO:0016746	transferase activity, transferring acyl groups	MF
1	18	2.47068670612	-	1.32e-01	GO:0016209	antioxidant activity	MF
1	18	2.47068670612	-	1.40e-01	GO:0005319	lipid transporter activity	MF
1	18	2.47068670612	-	1.40e-01	GO:0005545	1-phosphatidylinositol binding	MF
1	18	2.47068670612	-	1.57e-01	GO:0070577	lysine-acetylated histone binding	MF
39	711	2.4523081768	-	1.22e-10	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	BP
3	55	2.44421449475	-	1.37e-02	GO:0008104	protein localization	BP
2	37	2.43115834193	-	4.54e-02	GO:0071902	positive regulation of protein serine/threonine kinase activity	BP
2	37	2.43115834193	-	5.03e-02	GO:2001237	negative regulation of extrinsic apoptotic signaling pathway	BP
2	37	2.43115834193	-	5.29e-02	GO:0031623	receptor internalization	BP
3	56	2.41821928622	-	1.03e-02	GO:0001227	transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding	MF
3	57	2.39268419411	-	1.68e-02	GO:0048661	positive regulation of smooth muscle cell proliferation	BP
2	38	2.39268419411	-	2.38e-02	GO:0009409	response to cold	BP
2	38	2.39268419411	-	4.78e-02	GO:0021549	cerebellum development	BP
1	19	2.39268419411	-	1.32e-01	GO:0048148	behavioral response to cocaine	BP
1	19	2.39268419411	-	1.49e-01	GO:0032332	positive regulation of chondrocyte differentiation	BP
1	19	2.39268419411	-	1.49e-01	GO:0030220	platelet formation	BP
1	19	2.39268419411	-	1.57e-01	GO:0008589	regulation of smoothened signaling pathway	BP
1	19	2.39268419411	-	1.66e-01	GO:0010906	regulation of glucose metabolic process	BP
1	19	2.39268419411	-	1.74e-01	GO:0070932	histone H3 deacetylation	BP
1	19	2.39268419411	-	1.74e-01	GO:0043393	regulation of protein binding	BP
1	19	2.39268419411	-	1.05e-01	GO:0004653	polypeptide N-acetylgalactosaminyltransferase activity	MF
1	19	2.39268419411	-	1.32e-01	GO:0051213	dioxygenase activity	MF
1	19	2.39268419411	-	1.40e-01	GO:0001158	enhancer sequence-specific DNA binding	MF
1	19	2.39268419411	-	1.66e-01	GO:0017075	syntaxin-1 binding	MF
1	19	2.39268419411	-	1.74e-01	GO:0070064	proline-rich region binding	MF
2	39	2.3552094887	-	5.29e-02	GO:0043124	negative regulation of I-kappaB kinase/NF-kappaB signaling	BP
3	59	2.34293115892	-	1.60e-02	GO:0032092	positive regulation of protein binding	BP
9	177	2.34293115892	-	2.08e-05	GO:0000977	RNA polymerase II regulatory region sequence-specific DNA binding	MF
3	59	2.34293115892	-	2.04e-02	GO:0001047	core promoter binding	MF
10	199	2.3259151819	-	1.93e-05	GO:0003714	transcription corepressor activity	MF
3	60	2.31868361267	-	1.68e-02	GO:0034599	cellular response to oxidative stress	BP
1	20	2.31868361267	-	1.40e-01	GO:0031016	pancreas development	BP
1	20	2.31868361267	-	1.40e-01	GO:0002052	positive regulation of neuroblast proliferation	BP
1	20	2.31868361267	-	1.66e-01	GO:0043113	receptor clustering	BP
1	20	2.31868361267	-	1.74e-01	GO:0007051	spindle organization	BP
1	20	2.31868361267	-	1.74e-01	GO:0045662	negative regulation of myoblast differentiation	BP
1	20	2.31868361267	-	1.74e-01	GO:0045861	negative regulation of proteolysis	BP
1	20	2.31868361267	-	1.83e-01	GO:0001836	release of cytochrome c from mitochondria	BP
1	20	2.31868361267	-	1.40e-01	GO:0005112	Notch binding	MF
1	20	2.31868361267	-	1.66e-01	GO:0043539	protein serine/threonine kinase activator activity	MF
1	20	2.31868361267	-	1.74e-01	GO:0030159	receptor signaling complex scaffold activity	MF
18	368	2.28697475294	-	7.44e-09	GO:0003682	chromatin binding	MF
2	41	2.28305970294	-	5.81e-02	GO:0045740	positive regulation of DNA replication	BP
2	41	2.28305970294	-	5.81e-02	GO:0032947	protein complex scaffold	MF
2	42	2.24829428478	-	4.54e-02	GO:0045599	negative regulation of fat cell differentiation	BP
2	42	2.24829428478	-	6.07e-02	GO:1901215	negative regulation of neuron death	BP
2	42	2.24829428478	-	6.34e-02	GO:0031397	negative regulation of protein ubiquitination	BP
1	21	2.24829428478	-	1.32e-01	GO:0014059	regulation of dopamine secretion	BP
1	21	2.24829428478	-	1.40e-01	GO:0045333	cellular respiration	BP
1	21	2.24829428478	-	1.49e-01	GO:0071542	dopaminergic neuron differentiation	BP
1	21	2.24829428478	-	1.57e-01	GO:0045671	negative regulation of osteoclast differentiation	BP
1	21	2.24829428478	-	1.66e-01	GO:0001676	long-chain fatty acid metabolic process	BP
1	21	2.24829428478	-	1.74e-01	GO:0048870	cell motility	BP
1	21	2.24829428478	-	1.91e-01	GO:0051403	stress-activated MAPK cascade	BP
8	168	2.24829428478	-	3.06e-05	GO:0000981	RNA polymerase II transcription factor activity, sequence-specific DNA binding	MF
2	42	2.24829428478	-	4.30e-02	GO:0015485	cholesterol binding	MF
1	21	2.24829428478	-	1.49e-01	GO:0031210	phosphatidylcholine binding	MF
1	21	2.24829428478	-	1.83e-01	GO:0070412	R-SMAD binding	MF
3	63	2.24829428478	-	1.60e-02	GO:0008203	cholesterol metabolic process	BP
3	63	2.24829428478	-	1.68e-02	GO:0031647	regulation of protein stability	BP
8	171	2.22275919267	-	2.88e-04	GO:0008022	protein C-terminus binding	MF
2	43	2.21434695286	-	4.07e-02	GO:0045165	cell fate commitment	BP
2	43	2.21434695286	-	4.30e-02	GO:0001756	somitogenesis	BP
2	43	2.21434695286	-	6.62e-02	GO:0043966	histone H3 acetylation	BP
3	65	2.20320639525	-	2.23e-02	GO:0003705	transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding	MF
2	44	2.18118008892	-	5.55e-02	GO:0003151	outflow tract morphogenesis	BP
2	44	2.18118008892	-	7.18e-02	GO:0043525	positive regulation of neuron apoptotic process	BP
1	22	2.18118008892	-	1.40e-01	GO:0017158	regulation of calcium ion-dependent exocytosis	BP
1	22	2.18118008892	-	1.66e-01	GO:0017157	regulation of exocytosis	BP
1	22	2.18118008892	-	1.74e-01	GO:0015914	phospholipid transport	BP
1	22	2.18118008892	-	1.83e-01	GO:0035924	cellular response to vascular endothelial growth factor stimulus	BP
1	22	2.18118008892	-	1.83e-01	GO:1904886	beta-catenin destruction complex disassembly	BP
1	22	2.18118008892	-	1.91e-01	GO:0048278	vesicle docking	BP
1	22	2.18118008892	-	1.99e-01	GO:0016050	vesicle organization	BP
1	22	2.18118008892	-	1.74e-01	GO:1990841	promoter-specific chromatin binding	MF
1	22	2.18118008892	-	1.91e-01	GO:0035255	ionotropic glutamate receptor binding	MF
4	89	2.16487827659	-	9.64e-03	GO:0007179	transforming growth factor beta receptor signaling pathway	BP
2	45	2.14875861123	-	6.34e-02	GO:0014070	response to organic cyclic compound	BP
2	45	2.14875861123	-	6.90e-02	GO:0010595	positive regulation of endothelial cell migration	BP
16	360	2.14875861123	-	1.27e-08	GO:0043565	sequence-specific DNA binding	MF
5	114	2.12964978828	-	4.60e-03	GO:0006461	protein complex assembly	BP
2	46	2.1170497515	-	6.07e-02	GO:0010506	regulation of autophagy	BP
2	46	2.1170497515	-	6.62e-02	GO:0008542	visual learning	BP
2	46	2.1170497515	-	7.76e-02	GO:0016241	regulation of macroautophagy	BP
1	23	2.1170497515	-	1.57e-01	GO:0009617	response to bacterium	BP
1	23	2.1170497515	-	1.74e-01	GO:0009954	proximal/distal pattern formation	BP
1	23	2.1170497515	-	1.83e-01	GO:0031018	endocrine pancreas development	BP
1	23	2.1170497515	-	1.91e-01	GO:0048675	axon extension	BP
1	23	2.1170497515	-	1.99e-01	GO:0045648	positive regulation of erythrocyte differentiation	BP
1	23	2.1170497515	-	1.99e-01	GO:0000083	regulation of transcription involved in G1/S transition of mitotic cell cycle	BP
1	23	2.1170497515	-	2.07e-01	GO:0000715	nucleotide-excision repair, DNA damage recognition	BP
1	23	2.1170497515	-	1.99e-01	GO:0030332	cyclin binding	MF
1	23	2.1170497515	-	2.07e-01	GO:0030295	protein kinase activator activity	MF
3	71	2.07582708877	-	2.63e-02	GO:0060333	interferon-gamma-mediated signaling pathway	BP
41	981	2.06005438596	-	1.10e-10	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	BP
2	48	2.05564920684	-	5.29e-02	GO:0045600	positive regulation of fat cell differentiation	BP
2	48	2.05564920684	-	7.18e-02	GO:0009267	cellular response to starvation	BP
1	24	2.05564920684	-	1.49e-01	GO:0019369	arachidonic acid metabolic process	BP
1	24	2.05564920684	-	1.57e-01	GO:0002376	immune system process	BP
1	24	2.05564920684	-	1.66e-01	GO:0030878	thyroid gland development	BP
1	24	2.05564920684	-	1.99e-01	GO:0033137	negative regulation of peptidyl-serine phosphorylation	BP
1	24	2.05564920684	-	2.07e-01	GO:0051966	regulation of synaptic transmission, glutamatergic	BP
1	24	2.05564920684	-	2.15e-01	GO:0043388	positive regulation of DNA binding	BP
1	24	2.05564920684	-	2.15e-01	GO:0070423	nucleotide-binding oligomerization domain containing signaling pathway	BP
4	97	2.04069886537	-	8.49e-03	GO:0030182	neuron differentiation	BP
4	97	2.04069886537	-	1.18e-02	GO:0051726	regulation of cell cycle	BP
3	73	2.0357496494	-	1.03e-02	GO:0030216	keratinocyte differentiation	BP
3	73	2.0357496494	-	2.63e-02	GO:0007005	mitochondrion organization	BP
3	73	2.0357496494	-	3.56e-02	GO:0006283	transcription-coupled nucleotide-excision repair	BP
3	73	2.0357496494	-	2.42e-02	GO:0008144	drug binding	MF
13	319	2.02363881193	-	1.18e-05	GO:0019899	enzyme binding	MF
5	124	2.00834349206	-	4.97e-03	GO:0002223	stimulatory C-type lectin receptor signaling pathway	BP
5	125	1.99675551778	-	7.91e-03	GO:1901796	regulation of signal transduction by p53 class mediator	BP
3	75	1.99675551778	-	3.68e-02	GO:0061418	regulation of transcription from RNA polymerase II promoter in response to hypoxia	BP
2	50	1.99675551778	-	6.62e-02	GO:0071277	cellular response to calcium ion	BP
2	50	1.99675551778	-	7.47e-02	GO:0048146	positive regulation of fibroblast proliferation	BP
2	50	1.99675551778	-	8.35e-02	GO:0071560	cellular response to transforming growth factor beta stimulus	BP
1	25	1.99675551778	-	1.32e-01	GO:0007602	phototransduction	BP
1	25	1.99675551778	-	1.83e-01	GO:0019433	triglyceride catabolic process	BP
1	25	1.99675551778	-	1.99e-01	GO:0050772	positive regulation of axonogenesis	BP
1	25	1.99675551778	-	2.07e-01	GO:0002053	positive regulation of mesenchymal cell proliferation	BP
1	25	1.99675551778	-	2.07e-01	GO:0060612	adipose tissue development	BP
1	25	1.99675551778	-	2.23e-01	GO:0071353	cellular response to interleukin-4	BP
1	25	1.99675551778	-	2.23e-01	GO:0000188	inactivation of MAPK activity	BP
2	50	1.99675551778	-	7.76e-02	GO:0001085	RNA polymerase II transcription factor binding	MF
1	25	1.99675551778	-	2.15e-01	GO:0043014	alpha-tubulin binding	MF
1	25	1.99675551778	-	2.23e-01	GO:0046875	ephrin receptor binding	MF
13	329	1.97910765196	-	6.39e-06	GO:0000978	RNA polymerase II core promoter proximal region sequence-specific DNA binding	MF
4	102	1.96818636559	-	1.42e-02	GO:0051091	positive regulation of sequence-specific DNA binding transcription factor activity	BP
2	51	1.96818636559	-	8.05e-02	GO:0040008	regulation of growth	BP
10	255	1.96818636559	-	9.21e-05	GO:0001077	transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding	MF
4	102	1.96818636559	-	1.13e-02	GO:0001228	transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding	MF
2	51	1.96818636559	-	8.05e-02	GO:0035064	methylated histone binding	MF
3	77	1.95878766758	-	2.96e-02	GO:0009952	anterior/posterior pattern specification	BP
2	52	1.94017198942	-	6.90e-02	GO:0008344	adult locomotory behavior	BP
1	26	1.94017198942	-	1.74e-01	GO:0060338	regulation of type I interferon-mediated signaling pathway	BP
1	26	1.94017198942	-	1.99e-01	GO:0019216	regulation of lipid metabolic process	BP
1	26	1.94017198942	-	1.99e-01	GO:0070328	triglyceride homeostasis	BP
1	26	1.94017198942	-	2.07e-01	GO:0033077	T cell differentiation in thymus	BP
1	26	1.94017198942	-	2.07e-01	GO:0021983	pituitary gland development	BP
1	26	1.94017198942	-	2.07e-01	GO:0048709	oligodendrocyte differentiation	BP
1	26	1.94017198942	-	2.23e-01	GO:0000732	strand displacement	BP
1	26	1.94017198942	-	2.23e-01	GO:0008089	anterograde axonal transport	BP
1	26	1.94017198942	-	2.23e-01	GO:0050999	regulation of nitric-oxide synthase activity	BP
1	26	1.94017198942	-	2.31e-01	GO:0045931	positive regulation of mitotic cell cycle	BP
1	26	1.94017198942	-	2.31e-01	GO:0032728	positive regulation of interferon-beta production	BP
1	26	1.94017198942	-	2.31e-01	GO:0051721	protein phosphatase 2A binding	MF
1	26	1.94017198942	-	2.31e-01	GO:0035035	histone acetyltransferase binding	MF
5	132	1.91814568309	-	7.91e-03	GO:0050821	protein stabilization	BP
6	159	1.91269125299	-	4.00e-03	GO:0001666	response to hypoxia	BP
2	53	1.91269125299	-	4.54e-02	GO:0030317	flagellated sperm motility	BP
3	81	1.88572420539	-	4.35e-02	GO:0006338	chromatin remodeling	BP
2	54	1.88572420539	-	8.95e-02	GO:0051592	response to calcium ion	BP
2	54	1.88572420539	-	9.88e-02	GO:0045732	positive regulation of protein catabolic process	BP
1	27	1.88572420539	-	1.91e-01	GO:0030534	adult behavior	BP
1	27	1.88572420539	-	2.07e-01	GO:0016358	dendrite development	BP
1	27	1.88572420539	-	2.23e-01	GO:0001975	response to amphetamine	BP
1	27	1.88572420539	-	2.31e-01	GO:0090314	positive regulation of protein targeting to membrane	BP
1	27	1.88572420539	-	2.31e-01	GO:0043392	negative regulation of DNA binding	BP
1	27	1.88572420539	-	2.38e-01	GO:0043278	response to morphine	BP
1	27	1.88572420539	-	2.38e-01	GO:0009314	response to radiation	BP
1	27	1.88572420539	-	2.07e-01	GO:0004693	cyclin-dependent protein serine/threonine kinase activity	MF
20	545	1.87242738278	-	7.05e-08	GO:0006366	transcription from RNA polymerase II promoter	BP
4	109	1.87242738278	-	1.63e-02	GO:0071356	cellular response to tumor necrosis factor	BP
2	55	1.85925199403	-	9.57e-02	GO:0070373	negative regulation of ERK1 and ERK2 cascade	BP
17	471	1.8484912992	-	1.08e-06	GO:0045892	negative regulation of transcription, DNA-templated	BP
2	56	1.8332567855	-	7.76e-02	GO:0009612	response to mechanical stimulus	BP
1	28	1.8332567855	-	1.83e-01	GO:0007194	negative regulation of adenylate cyclase activity	BP
1	28	1.8332567855	-	1.83e-01	GO:0048791	calcium ion-regulated exocytosis of neurotransmitter	BP
1	28	1.8332567855	-	2.07e-01	GO:0003281	ventricular septum development	BP
1	28	1.8332567855	-	2.15e-01	GO:0048863	stem cell differentiation	BP
1	28	1.8332567855	-	2.23e-01	GO:0000422	mitophagy	BP
1	28	1.8332567855	-	2.31e-01	GO:0007528	neuromuscular junction development	BP
1	28	1.8332567855	-	2.46e-01	GO:0014047	glutamate secretion	BP
1	28	1.8332567855	-	2.46e-01	GO:0035666	TRIF-dependent toll-like receptor signaling pathway	BP
1	28	1.8332567855	-	2.46e-01	GO:0010332	response to gamma radiation	BP
1	28	1.8332567855	-	2.46e-01	GO:0032008	positive regulation of TOR signaling	BP
2	57	1.80772169339	-	1.02e-01	GO:0003684	damaged DNA binding	MF
2	58	1.78263071243	-	8.65e-02	GO:0021766	hippocampus development	BP
2	58	1.78263071243	-	9.26e-02	GO:0016525	negative regulation of angiogenesis	BP
1	29	1.78263071243	-	1.40e-01	GO:0042572	retinol metabolic process	BP
1	29	1.78263071243	-	1.91e-01	GO:0030163	protein catabolic process	BP
1	29	1.78263071243	-	2.07e-01	GO:0044344	cellular response to fibroblast growth factor stimulus	BP
1	29	1.78263071243	-	2.07e-01	GO:0051017	actin filament bundle assembly	BP
1	29	1.78263071243	-	2.15e-01	GO:0048167	regulation of synaptic plasticity	BP
1	29	1.78263071243	-	2.23e-01	GO:0045595	regulation of cell differentiation	BP
1	29	1.78263071243	-	2.31e-01	GO:0006400	tRNA modification	BP
1	29	1.78263071243	-	2.31e-01	GO:0010033	response to organic substance	BP
1	29	1.78263071243	-	2.31e-01	GO:0021915	neural tube development	BP
1	29	1.78263071243	-	2.38e-01	GO:0060412	ventricular septum morphogenesis	BP
1	29	1.78263071243	-	2.38e-01	GO:0000060	protein import into nucleus, translocation	BP
1	29	1.78263071243	-	2.38e-01	GO:1903146	regulation of mitophagy	BP
1	29	1.78263071243	-	2.38e-01	GO:0006284	base-excision repair	BP
1	29	1.78263071243	-	2.46e-01	GO:0046627	negative regulation of insulin receptor signaling pathway	BP
1	29	1.78263071243	-	2.54e-01	GO:0006513	protein monoubiquitination	BP
1	29	1.78263071243	-	2.54e-01	GO:0090307	mitotic spindle assembly	BP
1	29	1.78263071243	-	2.46e-01	GO:0004712	protein serine/threonine/tyrosine kinase activity	MF
1	29	1.78263071243	-	2.46e-01	GO:0042169	SH2 domain binding	MF
7	206	1.76146610243	-	4.13e-03	GO:0019904	protein domain specific binding	MF
2	59	1.7579686582	-	5.29e-02	GO:0016266	O-glycan processing	BP
2	59	1.7579686582	-	9.26e-02	GO:0050727	regulation of inflammatory response	BP
2	60	1.73372111195	-	8.35e-02	GO:0006968	cellular defense response	BP
2	60	1.73372111195	-	1.12e-01	GO:0030334	regulation of cell migration	BP
2	60	1.73372111195	-	1.18e-01	GO:0007059	chromosome segregation	BP
1	30	1.73372111195	-	2.15e-01	GO:0050873	brown fat cell differentiation	BP
1	30	1.73372111195	-	2.46e-01	GO:0042177	negative regulation of protein catabolic process	BP
1	30	1.73372111195	-	2.46e-01	GO:0001932	regulation of protein phosphorylation	BP
1	30	1.73372111195	-	2.54e-01	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	BP
1	30	1.73372111195	-	2.61e-01	GO:0007052	mitotic spindle organization	BP
1	30	1.73372111195	-	2.54e-01	GO:0005164	tumor necrosis factor receptor binding	MF
2	61	1.70987437	-	9.26e-02	GO:0042632	cholesterol homeostasis	BP
2	62	1.68641539717	-	1.05e-01	GO:0051289	protein homotetramerization	BP
2	62	1.68641539717	-	1.08e-01	GO:0006302	double-strand break repair	BP
2	62	1.68641539717	-	1.28e-01	GO:0045815	positive regulation of gene expression, epigenetic	BP
1	31	1.68641539717	-	2.15e-01	GO:0045907	positive regulation of vasoconstriction	BP
1	31	1.68641539717	-	2.46e-01	GO:0043200	response to amino acid	BP
1	31	1.68641539717	-	2.61e-01	GO:0006352	DNA-templated transcription, initiation	BP
1	31	1.68641539717	-	2.61e-01	GO:0006383	transcription from RNA polymerase III promoter	BP
1	31	1.68641539717	-	2.68e-01	GO:0070059	intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress	BP
1	31	1.68641539717	-	2.54e-01	GO:0008536	Ran GTPase binding	MF
3	94	1.6709853566	-	5.37e-02	GO:0008584	male gonad development	BP
2	63	1.66333178406	-	1.28e-01	GO:0019903	protein phosphatase binding	MF
12	379	1.65952017011	-	1.42e-04	GO:0008285	negative regulation of cell proliferation	BP
6	191	1.64814538024	-	9.78e-03	GO:0004672	protein kinase activity	MF
2	64	1.64061170756	-	9.88e-02	GO:0060337	type I interferon signaling pathway	BP
2	64	1.64061170756	-	1.18e-01	GO:0018107	peptidyl-threonine phosphorylation	BP
2	64	1.64061170756	-	1.28e-01	GO:0043154	negative regulation of cysteine-type endopeptidase activity involved in apoptotic process	BP
1	32	1.64061170756	-	2.07e-01	GO:0051480	regulation of cytosolic calcium ion concentration	BP
1	32	1.64061170756	-	2.07e-01	GO:0043588	skin development	BP
1	32	1.64061170756	-	2.23e-01	GO:0007498	mesoderm development	BP
1	32	1.64061170756	-	2.31e-01	GO:0030513	positive regulation of BMP signaling pathway	BP
1	32	1.64061170756	-	2.54e-01	GO:0070830	bicellular tight junction assembly	BP
1	32	1.64061170756	-	2.68e-01	GO:0071549	cellular response to dexamethasone stimulus	BP
1	32	1.64061170756	-	2.76e-01	GO:0070911	global genome nucleotide-excision repair	BP
1	32	1.64061170756	-	2.76e-01	GO:0010803	regulation of tumor necrosis factor-mediated signaling pathway	BP
1	32	1.64061170756	-	2.76e-01	GO:0032212	positive regulation of telomere maintenance via telomerase	BP
4	129	1.62938445213	-	3.09e-02	GO:0043524	negative regulation of neuron apoptotic process	BP
5	165	1.5962175882	-	1.49e-02	GO:0007507	heart development	BP
3	99	1.5962175882	-	5.37e-02	GO:0001764	neuron migration	BP
3	99	1.5962175882	-	6.17e-02	GO:0031175	neuron projection development	BP
1	33	1.5962175882	-	2.61e-01	GO:0007585	respiratory gaseous exchange	BP
1	33	1.5962175882	-	2.68e-01	GO:0045787	positive regulation of cell cycle	BP
1	33	1.5962175882	-	2.83e-01	GO:0043928	exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay	BP
2	66	1.5962175882	-	8.95e-02	GO:0003777	microtubule motor activity	MF
1	33	1.5962175882	-	2.23e-01	GO:0016874	ligase activity	MF
2	67	1.5745225171	-	1.25e-01	GO:0032088	negative regulation of NF-kappaB transcription factor activity	BP
2	68	1.55314886631	-	1.12e-01	GO:0006310	DNA recombination	BP
1	34	1.55314886631	-	2.83e-01	GO:0010634	positive regulation of epithelial cell migration	BP
1	34	1.55314886631	-	2.90e-01	GO:0000731	DNA synthesis involved in DNA repair	BP
1	34	1.55314886631	-	2.90e-01	GO:1990090	cellular response to nerve growth factor stimulus	BP
1	34	1.55314886631	-	2.83e-01	GO:0048487	beta-tubulin binding	MF
2	69	1.53208725078	-	1.02e-01	GO:0071300	cellular response to retinoic acid	BP
2	69	1.53208725078	-	1.42e-01	GO:0097190	apoptotic signaling pathway	BP
3	104	1.52513449014	-	5.22e-02	GO:0010468	regulation of gene expression	BP
1	35	1.51132869061	-	2.38e-01	GO:0086091	regulation of heart rate by cardiac conduction	BP
1	35	1.51132869061	-	2.46e-01	GO:0001890	placenta development	BP
1	35	1.51132869061	-	2.61e-01	GO:1901998	toxin transport	BP
1	35	1.51132869061	-	2.97e-01	GO:0070534	protein K63-linked ubiquitination	BP
50	1762	1.50146968841	-	3.33e-11	GO:0006351	transcription, DNA-templated	BP
2	71	1.49086458805	-	1.45e-01	GO:0007584	response to nutrient	BP
7	249	1.48796469755	-	7.55e-03	GO:0010628	positive regulation of gene expression	BP
23	824	1.47767313643	-	7.09e-08	GO:0003700	transcription factor activity, sequence-specific DNA binding	MF
6	215	1.47738135869	-	1.11e-02	GO:0001525	angiogenesis	BP
1	36	1.47068670612	-	2.38e-01	GO:0032467	positive regulation of cytokinesis	BP
1	36	1.47068670612	-	2.61e-01	GO:0001568	blood vessel development	BP
1	36	1.47068670612	-	2.90e-01	GO:0051402	neuron apoptotic process	BP
3	109	1.4573898835	-	7.37e-02	GO:0044325	ion channel binding	MF
2	73	1.45078714868	-	1.52e-01	GO:0001843	neural tube closure	BP
5	183	1.44683996416	-	2.14e-02	GO:0042981	regulation of apoptotic process	BP
3	111	1.43115834193	-	6.84e-02	GO:0007219	Notch signaling pathway	BP
3	111	1.43115834193	-	8.66e-02	GO:0016569	covalent chromatin modification	BP
1	37	1.43115834193	-	2.83e-01	GO:0051898	negative regulation of protein kinase B signaling	BP
1	37	1.43115834193	-	2.97e-01	GO:0048469	cell maturation	BP
1	37	1.43115834193	-	2.97e-01	GO:0071364	cellular response to epidermal growth factor stimulus	BP
1	37	1.43115834193	-	2.61e-01	GO:0001786	phosphatidylserine binding	MF
1	37	1.43115834193	-	3.11e-01	GO:0004407	histone deacetylase activity	MF
2	75	1.41179301706	-	1.02e-01	GO:0045666	positive regulation of neuron differentiation	BP
2	75	1.41179301706	-	1.59e-01	GO:0016925	protein sumoylation	BP
3	113	1.40539524586	-	9.24e-02	GO:0071222	cellular response to lipopolysaccharide	BP
2	76	1.39268419411	-	1.31e-01	GO:0043085	positive regulation of catalytic activity	BP
2	76	1.39268419411	-	1.73e-01	GO:1900034	regulation of cellular response to heat	BP
1	38	1.39268419411	-	2.07e-01	GO:0048468	cell development	BP
1	38	1.39268419411	-	2.61e-01	GO:0001942	hair follicle development	BP
1	38	1.39268419411	-	2.68e-01	GO:0001657	ureteric bud development	BP
1	38	1.39268419411	-	2.76e-01	GO:0045597	positive regulation of cell differentiation	BP
1	38	1.39268419411	-	2.76e-01	GO:0030199	collagen fibril organization	BP
1	38	1.39268419411	-	3.04e-01	GO:0038128	ERBB2 signaling pathway	BP
1	38	1.39268419411	-	3.11e-01	GO:0030155	regulation of cell adhesion	BP
2	77	1.37382516686	-	1.25e-01	GO:0030324	lung development	BP
2	77	1.37382516686	-	1.42e-01	GO:0060070	canonical Wnt signaling pathway	BP
2	77	1.37382516686	-	1.59e-01	GO:0032869	cellular response to insulin stimulus	BP
2	77	1.37382516686	-	1.66e-01	GO:0004843	thiol-dependent ubiquitin-specific protease activity	MF
33	1271	1.37325751191	-	7.30e-11	GO:0006355	regulation of transcription, DNA-templated	BP
2	78	1.3552094887	-	1.73e-01	GO:0006919	activation of cysteine-type endopeptidase activity involved in apoptotic process	BP
1	39	1.3552094887	-	2.76e-01	GO:0007190	activation of adenylate cyclase activity	BP
1	39	1.3552094887	-	2.83e-01	GO:0045071	negative regulation of viral genome replication	BP
1	39	1.3552094887	-	2.83e-01	GO:0090002	establishment of protein localization to plasma membrane	BP
1	39	1.3552094887	-	2.97e-01	GO:0043434	response to peptide hormone	BP
1	39	1.3552094887	-	3.04e-01	GO:0009411	response to UV	BP
1	39	1.3552094887	-	3.11e-01	GO:0007223	Wnt signaling pathway, calcium modulating pathway	BP
2	80	1.31868361267	-	1.52e-01	GO:0035264	multicellular organism growth	BP
1	40	1.31868361267	-	2.83e-01	GO:0048704	embryonic skeletal system morphogenesis	BP
1	40	1.31868361267	-	3.11e-01	GO:0032024	positive regulation of insulin secretion	BP
1	40	1.31868361267	-	3.11e-01	GO:0097191	extrinsic apoptotic signaling pathway	BP
1	40	1.31868361267	-	3.25e-01	GO:0045429	positive regulation of nitric oxide biosynthetic process	BP
1	40	1.31868361267	-	3.32e-01	GO:0010508	positive regulation of autophagy	BP
5	200	1.31868361267	-	4.24e-02	GO:0032403	protein complex binding	MF
11	444	1.30562745985	-	2.09e-03	GO:0043066	negative regulation of apoptotic process	BP
2	81	1.30076170467	-	1.80e-01	GO:0006890	retrograde vesicle-mediated transport, Golgi to ER	BP
2	81	1.30076170467	-	1.05e-01	GO:0036459	thiol-dependent ubiquitinyl hydrolase activity	MF
7	284	1.29821951011	-	2.16e-02	GO:0031625	ubiquitin protein ligase binding	MF
3	122	1.29483687072	-	6.17e-02	GO:0006629	lipid metabolic process	BP
1	41	1.28305970294	-	2.15e-01	GO:0006024	glycosaminoglycan biosynthetic process	BP
1	41	1.28305970294	-	2.90e-01	GO:0009725	response to hormone	BP
1	41	1.28305970294	-	2.97e-01	GO:0043010	camera-type eye development	BP
1	41	1.28305970294	-	3.04e-01	GO:0007566	embryo implantation	BP
4	166	1.26557227621	-	8.42e-02	GO:0046777	protein autophosphorylation	BP
7	292	1.25814207074	-	2.39e-02	GO:0016032	viral process	BP
2	84	1.24829428478	-	1.63e-01	GO:0001822	kidney development	BP
1	42	1.24829428478	-	2.38e-01	GO:0046426	negative regulation of JAK-STAT cascade	BP
1	42	1.24829428478	-	3.32e-01	GO:0006986	response to unfolded protein	BP
1	42	1.24829428478	-	3.39e-01	GO:0000302	response to reactive oxygen species	BP
1	42	1.24829428478	-	3.39e-01	GO:0045785	positive regulation of cell adhesion	BP
1	42	1.24829428478	-	3.18e-01	GO:0048365	Rac GTPase binding	MF
2	85	1.23122077142	-	1.52e-01	GO:0009887	animal organ morphogenesis	BP
1	43	1.21434695286	-	3.18e-01	GO:0042110	T cell activation	BP
1	43	1.21434695286	-	3.18e-01	GO:0032755	positive regulation of interleukin-6 production	BP
1	43	1.21434695286	-	3.45e-01	GO:0051496	positive regulation of stress fiber assembly	BP
1	43	1.21434695286	-	3.25e-01	GO:0046332	SMAD binding	MF
4	173	1.20598347992	-	7.31e-02	GO:0001701	in utero embryonic development	BP
3	131	1.19215120674	-	1.26e-01	GO:0010629	negative regulation of gene expression	BP
4	175	1.18940059573	-	6.16e-02	GO:0070374	positive regulation of ERK1 and ERK2 cascade	BP
1	44	1.18118008892	-	2.90e-01	GO:0035338	long-chain fatty-acyl-CoA biosynthetic process	BP
1	44	1.18118008892	-	2.90e-01	GO:0006631	fatty acid metabolic process	BP
1	44	1.18118008892	-	2.90e-01	GO:0048666	neuron development	BP
1	44	1.18118008892	-	2.97e-01	GO:0006342	chromatin silencing	BP
1	44	1.18118008892	-	3.11e-01	GO:0030178	negative regulation of Wnt signaling pathway	BP
1	44	1.18118008892	-	3.39e-01	GO:0006094	gluconeogenesis	BP
1	44	1.18118008892	-	3.45e-01	GO:0032760	positive regulation of tumor necrosis factor production	BP
1	44	1.18118008892	-	3.52e-01	GO:0032147	activation of protein kinase activity	BP
1	44	1.18118008892	-	3.58e-01	GO:0007077	mitotic nuclear envelope disassembly	BP
1	44	1.18118008892	-	2.90e-01	GO:0030276	clathrin binding	MF
1	44	1.18118008892	-	3.32e-01	GO:0000149	SNARE binding	MF
3	133	1.17029177278	-	1.47e-01	GO:0051092	positive regulation of NF-kappaB transcription factor activity	BP
2	89	1.16487827659	-	1.42e-01	GO:0007160	cell-matrix adhesion	BP
1	45	1.14875861123	-	1.99e-01	GO:0045596	negative regulation of cell differentiation	BP
1	45	1.14875861123	-	2.83e-01	GO:0006633	fatty acid biosynthetic process	BP
1	45	1.14875861123	-	3.04e-01	GO:0008015	blood circulation	BP
1	45	1.14875861123	-	3.25e-01	GO:0030900	forebrain development	BP
1	45	1.14875861123	-	3.32e-01	GO:0071363	cellular response to growth factor stimulus	BP
4	182	1.13281706736	-	7.86e-02	GO:0007596	blood coagulation	BP
1	46	1.1170497515	-	3.58e-01	GO:0008307	structural constituent of muscle	MF
3	139	1.10663313556	-	1.31e-01	GO:0007050	cell cycle arrest	BP
4	187	1.09371724767	-	7.31e-02	GO:0007420	brain development	BP
3	141	1.08602285588	-	1.47e-01	GO:0006260	DNA replication	BP
1	47	1.08602285588	-	2.90e-01	GO:0005544	calcium-dependent phospholipid binding	MF
1	47	1.08602285588	-	3.45e-01	GO:0003774	motor activity	MF
32	1518	1.07265563214	-	7.27e-08	GO:0003677	DNA binding	MF
1	48	1.05564920684	-	3.65e-01	GO:0019827	stem cell population maintenance	BP
1	48	1.05564920684	-	3.78e-01	GO:0042542	response to hydrogen peroxide	BP
1	48	1.05564920684	-	3.25e-01	GO:0030145	manganese ion binding	MF
2	97	1.04069886537	-	2.24e-01	GO:0071456	cellular response to hypoxia	BP
1	49	1.02590186344	-	3.78e-01	GO:0010212	response to ionizing radiation	BP
1	49	1.02590186344	-	3.52e-01	GO:0097110	scaffold protein binding	MF
1	49	1.02590186344	-	3.71e-01	GO:0004386	helicase activity	MF
1	49	1.02590186344	-	3.71e-01	GO:0043621	protein self-association	MF
3	147	1.02590186344	-	9.64e-02	GO:0046983	protein dimerization activity	MF
8	398	1.00398708701	-	2.02e-02	GO:0006357	regulation of transcription from RNA polymerase II promoter	BP
1	50	0.996755517783	-	3.32e-01	GO:0006906	vesicle fusion	BP
1	50	0.996755517783	-	3.71e-01	GO:0007269	neurotransmitter secretion	BP
1	50	0.996755517783	-	3.71e-01	GO:0071407	cellular response to organic cyclic compound	BP
1	50	0.996755517783	-	3.71e-01	GO:0008092	cytoskeletal protein binding	MF
22	1102	0.994134817624	-	1.02e-04	GO:0008270	zinc ion binding	MF
6	301	0.991954531519	-	5.45e-02	GO:0042493	response to drug	BP
4	204	0.968186365586	-	1.19e-01	GO:0006974	cellular response to DNA damage stimulus	BP
1	51	0.968186365586	-	3.65e-01	GO:0045860	positive regulation of protein kinase activity	BP
1	51	0.968186365586	-	3.96e-01	GO:0003743	translation initiation factor activity	MF
9	460	0.965046658056	-	1.90e-02	GO:0046982	protein heterodimerization activity	MF
3	156	0.940171989417	-	1.78e-01	GO:0043123	positive regulation of I-kappaB kinase/NF-kappaB signaling	BP
1	52	0.940171989417	-	3.39e-01	GO:0042157	lipoprotein metabolic process	BP
1	52	0.940171989417	-	3.90e-01	GO:0006417	regulation of translation	BP
2	105	0.926366189892	-	2.21e-01	GO:0006914	autophagy	BP
1	53	0.912691252995	-	2.90e-01	GO:0042472	inner ear morphogenesis	BP
1	53	0.912691252995	-	3.58e-01	GO:0007612	learning	BP
1	53	0.912691252995	-	3.65e-01	GO:0019233	sensory perception of pain	BP
1	53	0.912691252995	-	3.84e-01	GO:0071333	cellular response to glucose stimulus	BP
1	53	0.912691252995	-	3.96e-01	GO:0004702	signal transducer, downstream of receptor, with serine/threonine kinase activity	MF
5	266	0.907257366944	-	1.09e-01	GO:0000165	MAPK cascade	BP
2	108	0.885724205394	-	2.58e-01	GO:0009615	response to virus	BP
1	54	0.885724205394	-	3.65e-01	GO:0000902	cell morphogenesis	BP
1	54	0.885724205394	-	3.90e-01	GO:0030097	hemopoiesis	BP
1	54	0.885724205394	-	3.96e-01	GO:0006325	chromatin organization	BP
1	54	0.885724205394	-	4.02e-01	GO:0004197	cysteine-type endopeptidase activity	MF
3	162	0.885724205394	-	1.86e-01	GO:0007568	aging	BP
3	163	0.876846054048	-	1.40e-01	GO:0051607	defense response to virus	BP
1	55	0.859251994033	-	3.78e-01	GO:0042733	embryonic digit morphogenesis	BP
1	55	0.859251994033	-	3.78e-01	GO:0001570	vasculogenesis	BP
1	55	0.859251994033	-	3.78e-01	GO:0045665	negative regulation of neuron differentiation	BP
1	55	0.859251994033	-	2.97e-01	GO:0003824	catalytic activity	MF
1	56	0.8332567855	-	4.20e-01	GO:0032091	negative regulation of protein binding	BP
1	56	0.8332567855	-	3.96e-01	GO:0004722	protein serine/threonine phosphatase activity	MF
1	57	0.807721693393	-	3.39e-01	GO:0007338	single fertilization	BP
1	57	0.807721693393	-	3.45e-01	GO:0060395	SMAD protein signal transduction	BP
1	57	0.807721693393	-	3.84e-01	GO:0045669	positive regulation of osteoblast differentiation	BP
1	57	0.807721693393	-	3.96e-01	GO:0060041	retina development in camera-type eye	BP
3	171	0.807721693393	-	1.86e-01	GO:0042127	regulation of cell proliferation	BP
6	344	0.799309453577	-	1.44e-01	GO:0004674	protein serine/threonine kinase activity	MF
2	115	0.795121656614	-	3.21e-01	GO:0000184	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay	BP
3	174	0.78263071243	-	1.83e-01	GO:0051260	protein homooligomerization	BP
2	116	0.78263071243	-	2.91e-01	GO:0030308	negative regulation of cell growth	BP
1	58	0.78263071243	-	4.20e-01	GO:0017148	negative regulation of translation	BP
1	58	0.78263071243	-	3.84e-01	GO:0005546	phosphatidylinositol-4,5-bisphosphate binding	MF
7	410	0.76848653011	-	9.57e-02	GO:0016567	protein ubiquitination	BP
1	59	0.757968658196	-	4.26e-01	GO:0001933	negative regulation of protein phosphorylation	BP
1	59	0.757968658196	-	4.37e-01	GO:0031398	positive regulation of protein ubiquitination	BP
1	59	0.757968658196	-	4.37e-01	GO:0007249	I-kappaB kinase/NF-kappaB signaling	BP
2	120	0.733721111949	-	3.21e-01	GO:0033209	tumor necrosis factor-mediated signaling pathway	BP
1	60	0.733721111949	-	4.02e-01	GO:0051291	protein heterooligomerization	BP
1	60	0.733721111949	-	4.37e-01	GO:0021987	cerebral cortex development	BP
1	60	0.733721111949	-	3.90e-01	GO:0005518	collagen binding	MF
1	60	0.733721111949	-	4.14e-01	GO:0048306	calcium-dependent protein binding	MF
3	181	0.725728321196	-	1.35e-01	GO:0038095	Fc-epsilon receptor signaling pathway	BP
2	121	0.721748470283	-	3.17e-01	GO:0004713	protein tyrosine kinase activity	MF
1	61	0.709874369995	-	3.39e-01	GO:0006869	lipid transport	BP
3	183	0.709874369995	-	2.51e-01	GO:0061630	ubiquitin protein ligase activity	MF
1	62	0.686415397171	-	3.32e-01	GO:0007416	synapse assembly	BP
1	62	0.686415397171	-	3.90e-01	GO:0030512	negative regulation of transforming growth factor beta receptor signaling pathway	BP
1	62	0.686415397171	-	3.71e-01	GO:0008237	metallopeptidase activity	MF
1	63	0.663331784058	-	3.25e-01	GO:0007586	digestion	BP
1	63	0.663331784058	-	4.20e-01	GO:0032868	response to insulin	BP
1	63	0.663331784058	-	4.26e-01	GO:0009611	response to wounding	BP
1	63	0.663331784058	-	4.65e-01	GO:0006303	double-strand break repair via nonhomologous end joining	BP
3	189	0.663331784058	-	2.35e-01	GO:0005516	calmodulin binding	MF
2	127	0.651927020786	-	2.65e-01	GO:0008289	lipid binding	MF
1	64	0.640611707558	-	4.26e-01	GO:0008217	regulation of blood pressure	BP
1	64	0.640611707558	-	4.43e-01	GO:0035019	somatic stem cell population maintenance	BP
1	64	0.640611707558	-	4.54e-01	GO:0014068	positive regulation of phosphatidylinositol 3-kinase signaling	BP
1	64	0.640611707558	-	4.65e-01	GO:0000226	microtubule cytoskeleton organization	BP
7	453	0.624599389569	-	1.12e-01	GO:0008284	positive regulation of cell proliferation	BP
1	65	0.61824389453	-	4.14e-01	GO:0030183	B cell differentiation	BP
1	65	0.61824389453	-	4.32e-01	GO:0050796	regulation of insulin secretion	BP
7	460	0.602476578671	-	8.60e-02	GO:0007275	multicellular organism development	BP
1	66	0.5962175882	-	4.43e-01	GO:0009749	response to glucose	BP
1	66	0.5962175882	-	4.43e-01	GO:0030855	epithelial cell differentiation	BP
4	270	0.563796110507	-	3.08e-01	GO:0016579	protein deubiquitination	BP
3	203	0.560238291094	-	4.48e-01	GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process	BP
2	136	0.553148866308	-	2.98e-01	GO:0001501	skeletal system development	BP
1	68	0.553148866308	-	4.65e-01	GO:0034976	response to endoplasmic reticulum stress	BP
1	68	0.553148866308	-	4.86e-01	GO:0032436	positive regulation of proteasomal ubiquitin-dependent protein catabolic process	BP
1	69	0.53208725078	-	4.20e-01	GO:0060079	excitatory postsynaptic potential	BP
1	69	0.53208725078	-	4.92e-01	GO:0007265	Ras protein signal transduction	BP
2	138	0.53208725078	-	3.46e-01	GO:0051015	actin filament binding	MF
1	69	0.53208725078	-	4.97e-01	GO:0043130	ubiquitin binding	MF
3	207	0.53208725078	-	2.67e-01	GO:0008017	microtubule binding	MF
3	208	0.525134490138	-	4.37e-01	GO:0004871	signal transducer activity	MF
1	70	0.511328690613	-	3.39e-01	GO:0042391	regulation of membrane potential	BP
1	70	0.511328690613	-	4.43e-01	GO:0009791	post-embryonic development	BP
1	70	0.511328690613	-	5.02e-01	GO:0042795	snRNA transcription from RNA polymerase II promoter	BP
1	70	0.511328690613	-	4.76e-01	GO:0003690	double-stranded DNA binding	MF
10	706	0.499015429174	-	1.38e-01	GO:0042803	protein homodimerization activity	MF
1	71	0.490864588053	-	4.37e-01	GO:0098869	cellular oxidant detoxification	BP
1	71	0.490864588053	-	4.81e-01	GO:0071347	cellular response to interleukin-1	BP
1	71	0.490864588053	-	4.97e-01	GO:0033138	positive regulation of peptidyl-serine phosphorylation	BP
1	72	0.470686706116	-	4.60e-01	GO:0006816	calcium ion transport	BP
1	72	0.470686706116	-	4.92e-01	GO:0043410	positive regulation of MAPK cascade	BP
2	145	0.460702617543	-	6.53e-01	GO:0018105	peptidyl-serine phosphorylation	BP
1	73	0.450787148678	-	4.65e-01	GO:0050728	negative regulation of inflammatory response	BP
2	148	0.431158341929	-	3.97e-01	GO:0050852	T cell receptor signaling pathway	BP
1	75	0.411793017062	-	5.02e-01	GO:0019900	kinase binding	MF
5	377	0.404119089177	-	4.07e-01	GO:0019901	protein kinase binding	MF
1	76	0.392684194114	-	4.71e-01	GO:0007018	microtubule-based movement	BP
1	76	0.392684194114	-	5.02e-01	GO:0008286	insulin receptor signaling pathway	BP
1	76	0.392684194114	-	5.07e-01	GO:0002479	antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent	BP
1	76	0.392684194114	-	5.12e-01	GO:0007030	Golgi organization	BP
1	76	0.392684194114	-	5.02e-01	GO:0051117	ATPase binding	MF
2	153	0.383223864865	-	6.56e-01	GO:0018108	peptidyl-tyrosine phosphorylation	BP
1	77	0.373825166863	-	4.20e-01	GO:0007286	spermatid development	BP
1	77	0.373825166863	-	4.71e-01	GO:0031295	T cell costimulation	BP
1	77	0.373825166863	-	4.76e-01	GO:0005543	phospholipid binding	MF
1	77	0.373825166863	-	4.86e-01	GO:0016301	kinase activity	MF
1	77	0.373825166863	-	5.02e-01	GO:0030674	protein binding, bridging	MF
1	78	0.355209488696	-	4.49e-01	GO:0008544	epidermis development	BP
2	157	0.345990958666	-	3.72e-01	GO:0006511	ubiquitin-dependent protein catabolic process	BP
2	159	0.327728752274	-	6.58e-01	GO:0090090	negative regulation of canonical Wnt signaling pathway	BP
1	80	0.318683612671	-	5.07e-01	GO:0007229	integrin-mediated signaling pathway	BP
2	164	0.28305970294	-	6.55e-01	GO:0060271	cilium assembly	BP
1	83	0.265572276211	-	5.50e-01	GO:0006928	movement of cell or subcellular component	BP
2	168	0.248294284779	-	6.71e-01	GO:0030335	positive regulation of cell migration	BP
9	756	0.248294284779	-	4.39e-01	GO:0042802	identical protein binding	MF
4	337	0.244006926376	-	5.44e-01	GO:0004842	ubiquitin-protein transferase activity	MF
1	85	0.23122077142	-	4.02e-01	GO:0006486	protein glycosylation	BP
1	85	0.23122077142	-	4.71e-01	GO:1903955	positive regulation of protein targeting to mitochondrion	BP
1	85	0.23122077142	-	5.12e-01	GO:0006874	cellular calcium ion homeostasis	BP
1	86	0.214346952856	-	5.12e-01	GO:0007517	muscle organ development	BP
2	174	0.197668211709	-	6.62e-01	GO:0007411	axon guidance	BP
22	1943	0.17597314061	-	3.22e-02	GO:0046872	metal ion binding	MF
1	90	0.148758611228	-	5.72e-01	GO:0002020	protease binding	MF
1	91	0.132817067359	-	5.26e-01	GO:0009653	anatomical structure morphogenesis	BP
1	91	0.132817067359	-	5.63e-01	GO:0032355	response to estradiol	BP
97	8884	0.123530872198	-	3.46e-02	GO:0005515	protein binding	MF
1	92	0.117049751501	-	5.76e-01	GO:0019886	antigen processing and presentation of exogenous peptide antigen via MHC class II	BP
1	93	0.10145289645	-	5.45e-01	GO:0006464	cellular protein modification process	BP
1	93	0.10145289645	-	5.72e-01	GO:0030336	negative regulation of cell migration	BP
2	187	0.0937172476703	-	6.81e-01	GO:0000287	magnesium ion binding	MF
1	95	0.070756099227	-	4.60e-01	GO:0004867	serine-type endopeptidase inhibitor activity	MF
1	96	0.0556492068368	-	5.63e-01	GO:0006936	muscle contraction	BP
1	96	0.0556492068368	-	5.72e-01	GO:0042593	glucose homeostasis	BP
4	389	0.0369853625718	-	5.40e-01	GO:0007283	spermatogenesis	BP
2	196	0.0259018634428	-	6.64e-01	GO:0004872	receptor activity	MF
3	294	0.0259018634428	-	7.54e-01	GO:0043065	positive regulation of apoptotic process	BP
1	99	0.0112550874784	-	5.54e-01	GO:0016310	phosphorylation	BP
2	198	0.0112550874784	-	7.05e-01	GO:0006281	DNA repair	BP
1	100	-0.00324448221676	-	5.59e-01	GO:0005178	integrin binding	MF
11	1106	-0.0110923440394	-	3.75e-01	GO:0007165	signal transduction	BP
1	101	-0.0175997751938	-	6.29e-01	GO:0007062	sister chromatid cohesion	BP
1	102	-0.0318136344135	-	5.97e-01	GO:0001649	osteoblast differentiation	BP
1	102	-0.0318136344135	-	1.00e+00	GO:0043488	regulation of mRNA stability	BP
3	314	-0.0690465406125	-	4.98e-01	GO:0007399	nervous system development	BP
2	210	-0.0736338101082	-	6.69e-01	GO:0007268	chemical synaptic transmission	BP
5	529	-0.0845841096687	-	8.13e-01	GO:0006915	apoptotic process	BP
1	107	-0.100855278843	-	1.00e+00	GO:0000187	activation of MAPK activity	BP
4	435	-0.124259883178	-	1.00e+00	GO:0006468	protein phosphorylation	BP
1	109	-0.127572617219	-	1.00e+00	GO:0000082	G1/S transition of mitotic cell cycle	BP
1	110	-0.140748005967	-	6.29e-01	GO:0030168	platelet activation	BP
1	111	-0.153804158792	-	6.17e-01	GO:0045766	positive regulation of angiogenesis	BP
3	333	-0.153804158792	-	1.00e+00	GO:0051301	cell division	BP
1	113	-0.179567254857	-	1.00e+00	GO:0051082	unfolded protein binding	MF
12	1364	-0.188053720745	-	1.00e+00	GO:0003723	RNA binding	MF
1	116	-0.21736928757	-	5.41e-01	GO:0034765	regulation of ion transmembrane transport	BP
3	349	-0.221509017931	-	7.72e-01	GO:0005102	receptor binding	MF
2	234	-0.229753012025	-	1.00e+00	GO:0007067	mitotic nuclear division	BP
1	118	-0.242031341804	-	1.00e+00	GO:0005088	Ras guanyl-nucleotide exchange factor activity	MF
1	119	-0.25420605575	-	6.25e-01	GO:0006935	chemotaxis	BP
1	120	-0.266278888051	-	1.00e+00	GO:0090263	positive regulation of canonical Wnt signaling pathway	BP
1	120	-0.266278888051	-	1.00e+00	GO:0044267	cellular protein metabolic process	BP
1	120	-0.266278888051	-	1.00e+00	GO:0017124	SH3 domain binding	MF
12	1469	-0.295044472277	-	1.00e+00	GO:0005524	ATP binding	MF
1	125	-0.325172577104	-	1.00e+00	GO:0006470	protein dephosphorylation	BP
1	126	-0.336668215942	-	1.00e+00	GO:0002576	platelet degranulation	BP
1	127	-0.348072979214	-	5.85e-01	GO:0019221	cytokine-mediated signaling pathway	BP
1	127	-0.348072979214	-	1.00e+00	GO:0001934	positive regulation of protein phosphorylation	BP
1	127	-0.348072979214	-	5.54e-01	GO:0020037	heme binding	MF
3	382	-0.351854619757	-	1.00e+00	GO:0035556	intracellular signal transduction	BP
1	129	-0.370615547865	-	6.05e-01	GO:0007605	sensory perception of sound	BP
1	129	-0.370615547865	-	1.00e+00	GO:0042787	protein ubiquitination involved in ubiquitin-dependent protein catabolic process	BP
1	132	-0.4037824118	-	1.00e+00	GO:0006413	translational initiation	BP
1	134	-0.4254774829	-	6.01e-01	GO:0010951	negative regulation of endopeptidase activity	BP
1	135	-0.436203889493	-	5.63e-01	GO:0005975	carbohydrate metabolic process	BP
2	273	-0.452145433362	-	1.00e+00	GO:0003779	actin binding	MF
1	137	-0.457420375403	-	5.68e-01	GO:0005506	iron ion binding	MF
2	287	-0.524295219118	-	1.00e+00	GO:0006810	transport	BP
3	434	-0.535977024165	-	1.00e+00	GO:0045087	innate immune response	BP
1	146	-0.549212851322	-	1.00e+00	GO:0016887	ATPase activity	MF
4	587	-0.556604985552	-	1.00e+00	GO:0055114	oxidation-reduction process	BP
1	156	-0.644790511304	-	1.00e+00	GO:0007010	cytoskeleton organization	BP
1	161	-0.690305170557	-	1.00e+00	GO:0006397	mRNA processing	BP
1	162	-0.699238295327	-	1.00e+00	GO:0032496	response to lipopolysaccharide	BP
1	165	-0.725710506688	-	1.00e+00	GO:0008380	RNA splicing	BP
1	166	-0.734427723789	-	1.00e+00	GO:0016477	cell migration	BP
1	174	-0.802331788291	-	1.00e+00	GO:0002250	adaptive immune response	BP
1	174	-0.802331788291	-	1.00e+00	GO:0006412	translation	BP
2	354	-0.826993842525	-	7.75e-01	GO:0008283	cell proliferation	BP
1	178	-0.835121723408	-	1.00e+00	GO:0030246	carbohydrate binding	MF
1	179	-0.843204069706	-	1.00e+00	GO:0003676	nucleic acid binding	MF
2	366	-0.875088130726	-	1.00e+00	GO:0006954	inflammatory response	BP
1	199	-0.996012912986	-	1.00e+00	GO:0007049	cell cycle	BP
1	199	-0.996012912986	-	1.00e+00	GO:0007601	visual perception	BP
1	203	-1.02472420963	-	1.00e+00	GO:0050900	leukocyte migration	BP
1	204	-1.03181363441	-	1.00e+00	GO:0006898	receptor-mediated endocytosis	BP
1	212	-1.08730874701	-	1.00e+00	GO:0006886	intracellular protein transport	BP
1	212	-1.08730874701	-	1.00e+00	GO:0005198	structural molecule activity	MF
1	224	-1.1667432145	-	7.26e-01	GO:0003924	GTPase activity	MF
2	456	-1.19227830661	-	7.74e-01	GO:0007155	cell adhesion	BP
1	230	-1.20487834339	-	7.27e-01	GO:0061024	membrane organization	BP
3	694	-1.2132176443	-	6.32e-01	GO:0005509	calcium ion binding	MF
1	235	-1.23590523901	-	1.00e+00	GO:0007166	cell surface receptor signaling pathway	BP
1	281	-1.49381461266	-	7.31e-01	GO:0005096	GTPase activator activity	MF
2	571	-1.5167352278	-	2.46e-01	GO:0043547	positive regulation of GTPase activity	BP
1	286	-1.51925962922	-	5.35e-01	GO:0045296	cadherin binding	MF
1	295	-1.56395943669	-	7.26e-01	GO:0007267	cell-cell signaling	BP
1	310	-1.63551269772	-	5.29e-01	GO:0000166	nucleotide binding	MF
1	350	-1.81059940427	-	3.78e-01	GO:0015031	protein transport	BP
1	476	-2.25420605575	-	2.69e-01	GO:0030154	cell differentiation	BP
1	861	-3.10925771984	-	5.30e-01	GO:0007186	G-protein coupled receptor signaling pathway	BP
